Design of a Reciprocal Injection Device for Stability Studies of Parenteral Biological Drug Products

Formulation screening, essential for assessing the impact of physical, chemical, and mechanical stresses on protein stability, plays a critical role in biologics drug product development. This research introduces a Reciprocal Injection Device (RID) designed to accelerate formulation screening by probing protein stability under intensified stress conditions within prefilled syringes. This versatile device is designed to accommodate a broad spectrum of injection parameters and diverse syringe dimensions. A commercial drug product was employed as a model monoclonal antibody formulation. Our findings effectively highlight the efficacy of the RID in assessing concentration-dependent protein stability. This device exhibits significant potential to amplify the influences of interfacial interactions, such as those with buffer salts, excipients, air, metals, and silicone oils, commonly found in combination drug products, and to evaluate the protein stability under varied stresses.

Modulation of lipid profile by secretory phospholipase A2 group IIA: Verification with a transgenic mouse model

We previously demonstrated a positive relation of secretory phospholipase A2 group IIA (sPLA2-IIA) with circulating high-density lipoprotein cholesterol (HDL-C) in patients with coronary artery disease, and sPLA2-IIA increased cholesterol efflux in THP-1 cells through peroxisome proliferator-activated receptor-γ (PPAR-γ)/liver X receptor α/ATP-binding cassette transporter A1 (ABCA1) signaling pathway. The aim of the present study was to examine the role of sPLA2-IIA over-expression on lipid profile in a transgenic mouse model. Fifteen apoE-/- and C57BL/7 female mice received bone marrow transplantation from transgenic SPLA2-IIA mice, and treated with specific PPAR-γ inhibitor GW9662. High fat diet was given after one week of bone marrow transplantation, and animals were sacrificed after twelve weeks. Immunohistochemical staining showed over-expression of sPLA2-IIA protein in the lung and spleen. The circulating level of HDL-C, but not that of low-density lipoprotein cholesterol (LDL-C), total cholesterol, or total triglyceride, was increased by sPLA2-IIA over-expression, and was subsequently reversed by GW9662 treatment. Over-expression of sPLA2-IIA resulted in augmented expression of cholesterol transporter ABCA1 at mRNA level in the aortas, and at protein level in macrophages, co-localized with macrophage specific antigen CD68. GW9662 exerted potent inhibitory effects on sPLA2-IIA-induced ABCA1 expression. Conclusively, we demonstrated the effects of sPLA2-IIA on circulating HDL-C level and the expression of ABCA1, possibly through regulation of PPAR-γ signaling in transgenic mouse model, that is in concert with the conditions in patients with coronary artery disease.

The Plasmodium vivax MSP1P-19 is involved in binding of reticulocytes through interactions with the membrane proteins band3 and CD71

The parasite Plasmodium vivax preferentially invades human reticulocytes. Its merozoite surface protein 1 paralog (PvMSP1P), particularly the 19-kDa C-terminal region (PvMSP1P-19), has been shown to bind to reticulocytes and this binding can be inhibited by antisera obtained by PvMSP1P-19 immunization. The molecular mechanism of interactions between PvMSP1P-19 and reticulocytes during P. vivax invasion, however, remains unclear. In this study, we analyzed the ability of MSP1P-19 to bind to different concentrations of reticulocytes and confirmed its reticulocyte preference. LC-MS analysis was used to identify two potential reticulocyte receptors, band3 and CD71, that interact with MSP1P-19. Both PvMSP1P-19 and its sister taxon Plasmodium cynomolgi MSP1P-19 (PcMSP1P-19) were found to bind to the extracellular loop (loop 5) of band3, where the interaction of MSP1P-19 with band3 was chymotrypsin-sensitive. Antibodies against band3-P5, CD71, and MSP1P-19 reduced the binding activity of PvMSP1P-19 and PcMSP1P-19 to reticulocytes, while MSP1P-19 proteins inhibited P. falciparum invasion in vitro in a concentration-dependent manner. To sum up, identification and characterization of the reticulocyte receptor is important for understanding the binding of reticulocytes by MSP1P-19.

Proinflammatory phenotype of B10 and B10pro cells elicited by TNF-α in rheumatoid arthritis

OBJECTIVES

B10 and B10pro cells suppress immune responses via secreting interleukin (IL)-10. However, their regulators and underlying mechanisms, especially in human autoimmune diseases, are elusive. This study aimed to address these questions in rheumatoid arthritis (RA), one of the most common highly disabling autoimmune diseases.

METHODS

The frequencies and functions of B10 and B10pro cells in healthy individuals and patients with RA were first analysed. The effects of proinflammatory cytokines, particularly tumour necrosis factor (TNF)-α on the quantity, stability and pathogenic phenotype of these cells, were then assessed in patients with RA before and after anti-TNF therapy. The underlying mechanisms were further investigated by scRNA-seq database reanalysis, transcriptome sequencing, TNF-α-/- and B cell-specific SHIP-1-/- mouse disease model studies.

RESULTS

TNF-α was a key determinant for B10 cells. TNF-α elicited the proinflammatory feature of B10 and B10pro cells by downregulating IL-10, and upregulating interferon-γ and IL-17A. In patients with RA, B10 and B10pro cells were impaired with exacerbated proinflammatory phenotype, while anti-TNF therapy potently restored their frequencies and immunosuppressive functions, consistent with the increased B10 cells in TNF-α-/- mice. Mechanistically, TNF-α diminished B10 and B10pro cells by inhibiting their glycolysis and proliferation. TNF-α also regulated the phosphatidylinositol phosphate signalling of B10 and B10pro cells and dampened the expression of SHIP-1, a dominant phosphatidylinositol phosphatase regulator of these cells.

CONCLUSIONS

TNF-α provoked the proinflammatory phenotype of B10 and B10pro cells by disturbing SHIP-1 in RA, contributing to the disease development. Reinstating the immunosuppressive property of B10 and B10pro cells might represent novel therapeutic approaches for RA.

The Association Between the Triglyceride to High-Density Lipoprotein Cholesterol Ratio and the Incidence of Type 2 Diabetes Mellitus in the Japanese Population

Abstract Aims: To explore whether the triglyceride to high-density lipoprotein cholesterol ratio (TG/HDL-C) was independently associated with the risk of incident type 2 diabetes mellitus (T2DM) in a large Japanese cohort. Methods: A secondary analysis was performed using open-access data from a retrospective cohort study. A total of 12,716 eligible participants who had standard medical examinations at the Murakami Memorial Hospital were included in this study. New-onset T2DM was the main outcome during follow-up. The risk of T2DM based on the TG/HDL-C ratio was evaluated using Cox regression analysis and Kaplan-Meier analysis. Subgroup analysis was performed to understand further the significance of the TG/HDL-C ratio in particular populations. To assess the potential of the TG/HDL-C ratio for predicting T2DM, a receiver operating characteristic (ROC) analysis was performed. Results: One hundred fifty new-onset T2DM cases were observed during a median follow-up of 5.39 years. The incidence of T2DM increased with a rise in the TG/HDL-C ratio based on the Kaplan-Meier curves (P < 0.0001). After controlling for potential confounding variables, the TG/HDL-C ratio was positively related to incidence of T2DM (hazard ratio = 1.08, 95% confidence interval: 1.01-1.15, P = 0.0239). In subgroup analysis, those with a body mass index of ≥18.5 and <24 kg/m2 showed a significantly positive relationship. The area under the ROC curve for the TG/HDL-C ratio as a T2DM predictor was 0.684. The optimal TG/HDL-C ratio cutoff value for T2DM was 1.609, with a sensitivity of 54.7% and a specificity of 73.6%. Conclusion: The authors' results showed a significant relationship between the TG/HDL-C ratio and the incidence of T2DM in the Japanese population.

Identification of Surfactant Impact on a Monoclonal Antibody Characterization via HPLC-Separation Based and Biophysical Methods

PURPOSE OR OBJECTIVE

Surfactants, including polysorbates and poloxamers, play a crucial role in the formulation of therapeutic proteins by acting as solubilizing and stabilizing agents. They help prevent protein aggregation and adsorption, thereby enhancing the stability of drug substance and products., However, it is important to note that utilizing high concentrations of surfactants in protein formulations can present significant analytical challenges, which can ultimately affect the product characterization.

METHODS

In our study, we specifically investigated the impact of elevated surfactant concentrations on the characterization of monoclonal antibodies. We employed various analytical techniques including size-exclusion chromatography (SEC), capillary electrophoresis (CE-SDS), a cell based functional assay, and biophysical characterization.

RESULTS

The findings of our study indicate that higher levels of Polysorbate 80 (PS-80) have adverse effects on the measured purity, biological activity, and biophysical characterization of biologic samples. Specifically, the elevated levels of PS-80 cause analytical interferences, which can significantly impact the accuracy and reliability of analytical studies.

CONCLUSIONS

Our study results highlight a significant risk in analytical investigations, especially in studies involving the isolation and characterization of impurities. It is important to be cautious of surfactant concentrations, as they can become more concentrated during common sample manipulations like buffer exchange. Indeed, the research presented in this work emphasizes the necessity to evaluate the impact on analytical assays when there are substantial alternations in the matrix composition. By doing so, valuable insights can be gained regarding potential challenges associated with assay development and characterization of biologics with complex formulations.

Impaired local Vitamin D3 metabolism contributes to IL-36g overproduction in epithelial cells in chronic rhinosinusitis with nasal polyps

BACKGROUND

Vitamin D (VD) possesses immunomodulatory properties, but its role in chronic rhinosinusitis with nasal polyps (CRSwNP) remains poorly studied. Herein, we aim to explore the regulation and function of VD3 in CRSwNP.

METHODS

25-hydroxyvitamin D3 (25VD3) levels in serum and tissue lysates were detected by ELISA. The expression of VD receptor (VDR) and cytochrome P450 family 27 subfamily B member 1 (CYP27B1), the enzyme that converts 25VD3 to the active 1,25-hydroxyvitamin D3 (1,25VD3), and their expression regulation in human nasal epithelial cells (HNECs) were studied by RT-PCR, western blotting, immunofluorescence, and flow cytometry. RNA sequencing was performed to identify genes regulated by 1,25VD3 in HNECs. HNECs and polyp tissue explants were treated with 1,25VD3, 25VD3, and dexamethasone.

RESULTS

25VD3 levels in serum and nasal tissue lysates were decreased in patients with eosinophilic and noneosinophilic CRSwNP than control subjects. The expression of VDR and CYP27B1 were reduced in eosinophilic and noneosinophilic CRSwNP, particularly in nasal epithelial cells. VDR and CYP27B1 expression in HNECs were downregulated by interferon y and poly (I:C). Polyp-derived epithelial cells demonstrated an impaired ability to convert 25VD3 to 1,25VD3 than control tissues. 1,25VD3 and 25VD3 suppressed IL-36y production in HNECs and polyp tissues, and the effect of 25VD3 was abolished by siCYP27B1 treatment. Tissue 25VD3 levels negatively correlated with IL-36y expression and neutrophilic inflammation in CRSwNP.

CONCLUSION

Reduced systemic 25VD3 level, local 1,25VD3 generation and VDR expression result in impaired VD3 signaling activation in nasal epithelial cells, thereby exaggerating IL-36y production and neutrophilic inflammation in CRSwNP.

Role of Galectin-3 in intervertebral disc degeneration: an experimental study

BACKGROUND

This study investigated the role of Galectin-3 in the degeneration of intervertebral disc cartilage.

METHODS

The patients who underwent lumbar spine surgery due to degenerative disc disease were recruited and divided into Modic I, Modic II, and Modic III; groups. HE staining was used to detect the pathological changes in endplates. The changes of Galectin-3, MMP3, Aggrecan, CCL3, and Col II were detected by immunohistochemistry, RT-PCR, and Western blot. MTT and flow cytometry were used to detect cartilage endplate cell proliferation, cell cycle, and apoptosis.

RESULTS

With the progression of degeneration (from Modic I to III), the chondrocytes and density of the cartilage endplate of the intervertebral disc decreased, and the collagen arrangement of the cartilage endplate of the intervertebral disc was broken and calcified. Meanwhile, the expressions of Aggrecan, Col II, Galectin-3, Aggrecan, and CCL3 gradually decreased. After treatment with Galectin-3 inhibitor GB1107, the proliferation of rat cartilage end plate cells was significantly reduced (P < 0.05). GB1107 (25 µmol/L) also significantly promoted the apoptosis of cartilage endplate cells (P < 0.05). Moreover, the percentage of cartilage endplate cells in the G1 phase was significantly higher, while that in the G2 and S phases was significantly lower (P < 0.05). Additionally, the mRNA and protein expression levels of MMP3, CCL3, and Aggrecan in rat cartilage end plate cells were lower than those in the control group.

CONCLUSIONS

Galectin-3 decreases with the progression of the cartilage endplate degeneration of the intervertebral disc. Galectin-3 may affect intervertebral disc degeneration by regulating the degradation of the extracellular matrix.

Efficacy and safety of rademikibart (CBP-201), a next-generation mAb targeting IL-4Rα, in adults with moderate to severe atopic dermatitis: A phase 2 randomized trial (CBP-201-WW001)

BACKGROUND

Rademikibart (CBP-201) is a next-generation IL-4 receptor alpha-targeting antibody.

OBJECTIVE

We sought to evaluate rademikibart in adults with moderate to severe atopic dermatitis.

METHODS

A total of 226 patients were randomized, double-blind, to subcutaneous rademikibart (300 mg every 2 weeks [Q2W], 150 mg Q2W, 300 mg every 4 weeks [Q4W]; plus 600-mg loading dose) or placebo. Randomization began in July 2020. The trial was completed in October 2021.

RESULTS

The WW001 phase 2 trial achieved its primary end point: significant percent reduction from baseline in least-squares mean Eczema Area Severity Index (EASI) to week 16 with rademikibart 300 mg Q2W (-63.0%; P = .0007), 150 mg Q2W (-57.6%; P = .0067), 300 mg Q4W (-63.5%; P = .0004) versus placebo (-39.7%). EASI scores decreased significantly with 300 mg Q2W and Q4W at the earliest assessment (week 2), with no evidence of plateauing by week 16. Significant improvements were also observed in secondary end points, including pruritus. Across the primary and secondary end points, efficacy tended to be comparable with 300 mg Q2W and Q4W dosing. Rademikibart and placebo had similar, low incidence of treatment-emergent adverse events (TEAEs) (48% vs 54%), serious TEAEs (1.8% vs 3.6%), TEAEs leading to treatment discontinuation (1.2% vs 1.8%), conjunctivitis of unspecified cause (2.9% vs 0%), herpes (0.6% vs 1.8%), and injection-site reactions (1.8% vs 1.8%). Although no discontinuations were attributed to coronavirus disease 2019, pandemic-related restrictions likely had an impact on trial conduct.

CONCLUSIONS

Rademikibart was efficacious and well tolerated at Q2W and Q4W intervals. Q4W dosing is a more convenient frequency than approved for current therapies.

Bifenthrin induces changes in clinical poisoning symptoms, oxidative stress, DNA damage, histological characteristics, and transcriptome in Chinese giant salamander (Andrias davidianus) larvae

Bifenthrin (BF) is a broad-spectrum insecticide that has gained widespread use due to its high effectiveness. However, there is limited research on the potential toxic effects of bifenthrin pollution on amphibians. This study aimed to investigate the 50 % lethal concentration (LC50) and safety concentration of Chinese giant salamanders (CGS) exposed to BF (at 0, 6.25,12.5,25 and 50 μg/L BF) for 96 h. Subsequently, CGS were exposed to BF (at 0, 0.04, and 4 μg/L BF) for one week to investigate its toxic effects. Clinical poisoning symptoms, liver pathology, oxidative stress factors, DNA damage, and transcriptome differences were observed and analyzed. The results indicate that exposure to BF at 4 μg/L significantly decreased the adenosine-triphosphate (ATP), superoxide dismutase (SOD), glutathione (GSH), and catalase (CAT) contents in the brain, liver, and kidney of CGS. Additionally, the study found that the malondialdehyde (MDA), reactive oxygen species (ROS), and 8-hydroxydeoxyguanosine (8-OHdG) contents were increased. The liver tissue exhibited significant inflammatory reactions and structural malformations. RNA-seq analysis of the liver showed that BF caused abnormal antioxidant indices of CGS. This affected molecular function genes such as catalytic activity, ATP-dependent activity, metabolic processes, signaling and immune system processes, behavior, and detoxification, which were significantly upregulated, resulting in the differential genes significantly enriched in the calcium signaling pathway, PPARα signaling pathway and NF-kB signaling pathway. The results suggest that BF induces the abnormal production of free radicals, which overwhelms the body's self-defense system, leading to varying degrees of oxidative stress. This can result in oxidative damage, DNA damage, abnormal lipid metabolism, autoimmune diseases, clinical poisoning symptoms, and tissue inflammation. This work provides a theoretical basis for the rational application of bifenthrin and environmental risk assessment, as well as scientific guidance for the conservation of amphibian populations.

Increased m6A modification of BDNF mRNA via FTO promotes neuronal apoptosis following aluminum-induced oxidative stress

N6-methyladenosine (m6A) RNA modification is a new epigenetic molecular mechanism involved in various biological or pathological processes. Exposure to aluminum (Al) has been considered to promote neuronal apoptosis resulting in cognitive dysfunction, yet whether m6A modification participates in the underlying mechanism remains largely unknown. Here, rats exposed to aluminum-maltolate [Al(mal)3] for 90 days showed impaired learning and memory function and elevated apoptosis, which were related to the increased m6A level and decreased fat mass and obesity-associated protein (FTO, an m6A demethylase) in the hippocampus. Accordingly, similar results presented in PC12 cells following Al(mal)3 treatment and FTO overexpression relieved the increased apoptosis and m6A level in vitro. Next, we identified brain-derived neurotrophic factor (BDNF) as the functional downstream target of FTO in a m6A-dependent manner. Furthermore, it was found that as the onset of aluminum neurotoxicity, oxidative stress may be the upstream regulator of FTO in aluminum-induced apoptosis. Taken together, these results suggest that increased m6A modification of BDNF mRNA via FTO promotes neuronal apoptosis following aluminum-induced oxidative stress.

Association of red cell distribution width/albumin ratio and in hospital mortality in patients with atrial fibrillation base on medical information mart for intensive care IV database

BACKGROUND

Atrial fibrillation (AF) is a common cardiac arrhythmia. The ratio of red cell distribution width (RDW) to albumin has been recognized as a reliable prognostic marker for poor outcomes in a variety of diseases. However, the evidence regarding the association between RDW to albumin ratio (RAR) and in hospital mortality in patients with AF admitted to the Intensive Care Unit (ICU) currently was unclear. The purpose of this study was to explore the association between RAR and in hospital mortality in patients with AF in the ICU.

METHODS

This retrospective cohort study used data from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database for the identification of patients with atrial fibrillation (AF). The primary endpoint investigated was in-hospital mortality. Multivariable-adjusted Cox regression analysis and forest plots were utilized to evaluate the correlation between the RAR and in-hospital mortality among patients with AF admitted to ICU. Additionally, receiver operating characteristic (ROC) curves were conducted to assess and compare the predictive efficacy of RDW and the RAR.

RESULTS

Our study included 4,584 patients with AF with a mean age of 75.1 ± 12.3 years, 57% of whom were male. The in-hospital mortality was 20.3%. The relationship between RAR and in-hospital mortality was linear. The Cox proportional hazard model, adjusted for potential confounders, found a high RAR independently associated with in hospital mortality. For each increase of 1 unit in RAR, there is a 12% rise in the in-hospital mortality rate (95% CI 1.06-1.19). The ROC curves revealed that the discriminatory ability of the RAR was better than that of RDW. The area under the ROC curves (AUCs) for RAR and RDW were 0.651 (95%CI: 0.631-0.671) and 0.599 (95% CI: 0.579-0.620).

CONCLUSIONS

RAR is independently correlated with in hospital mortality and in AF. High level of RAR is associated with increased in-hospital mortality rates.

SerpinB3/B4 Abates Epithelial Cell-Derived CXCL8/IL-8 Expression in Chronic Rhinosinusitis with Nasal Polyps

Background

Serine proteinase inhibitors, clade B, member 3 (SerpinB3) and B4 are highly similar in amino acid sequences and associated with inflammation regulation. We investigated SerpinB3 and B4 expression and their roles in chronic rhinosinusitis with nasal polyps (CRSwNP).

Methods

The expression of SerpinB3 and B4 in nasal mucosa tissues, brush cells, and secretions from CRSwNP patients was measured, and their regulation by inflammatory cytokines were investigated. Their functions were also analyzed using air-liquid interface (ALI)-cultured primary human nasal epithelial cells (HNECs) and transcriptomic analysis.

Results

Both SerpinB3 and B4 expression was higher in nasal mucosa, brush cells, and secretions from eosinophilic (E) CRSwNP and nonECRSwNP patients than in healthy controls. Immunofluorescence staining indicated that SerpinB3 and B4 were primarily expressed in epithelial cells and their expression was higher in CRSwNP patients. SerpinB3 and B4 expression was upregulated by interleukin-4 (IL-4), IL-5, IL-6, and IL-17a. Transcriptomic analysis identified differentially expressed genes (DEGs) in response to recombinant SerpinB3 and B4 stimulation. Both the DEGs of SerpinB3 and B4 were associated with disease genes of nasal polyps and inflammation in DisGeNET database. Pathway enrichment indicated that downregulated DEGs of SerpinB3 and B4 were both enriched in cytokine-cytokine receptor interactions, with CXCL8 as the hub gene in the protein-protein interaction networks. Furthermore, CXCL8/IL-8 expression was downregulated by recombinant SerpinB3 and B4 protein in ALI-cultured HNECs, and upregulated when knockdown of SerpinB3/B4.

Conclusion

SerpinB3/B4 expression is upregulated in nasal mucosa of CRSwNP patients. SerpinB3/B4 may play an anti-inflammatory role in CRSwNP by inhibiting the expression of epithelial cell-derived CXCL8/IL-8.

The genetic diversity of Oncomelania hupensis robertsoni, intermediate hosts of Schistosoma japonicum in hilly regions of China, using microsatellite markers

BACKGROUND

The elimination of schistosomiasis remains a challenging task, with current measures primarily focused on the monitoring and control of Oncomelania hupensis (O. hupensis) snail, the sole intermediate host of Schistosome japonicum. Given the emerging, re-emerging, and persistent habitats of snails, understanding their genetic diversity might be essential for their successful monitoring and control. The aims of this study were to analyze the genetic diversity of Oncomelania hupensis robertsoni (O. h. robertsoni) using microsatellite DNA markers; and validate the applicability of previously identified microsatellite loci for O. hupensis in hilly regions.

METHODS

A total of 17 populations of O. h. robertsoni from Yunnan Province in China were selected for analysis of genetic diversity using six microsatellite DNA polymorphic loci (P82, P84, T4-22, T5-11, T5-13, and T6-27).

RESULTS

The number of alleles among populations ranged from 0 to 19, with an average of 5. The average ranges of expected (He) and observed (Ho) heterozygosity within populations were 0.506 to 0.761 and 0.443 to 0.792, respectively. The average fixation index within the population ranged from - 0.801 to 0.211. The average polymorphic information content (PIC) within the population ranged from 0.411 to 0.757, appearing to be polymorphic for all loci (all PIC > 0.5), except for P28 and P48. A total of 68 loci showed significant deviations from Hardy-Weinberg equilibrium (P < 0.05), and pairwise Fst values ranged from 0.051 to 0.379. The analysis of molecular variance indicated that 88% of the variation occurred within snail populations, whereas 12% occurred among snail populations. Phylogenetic trees and principal coordinate analysis revealed two distinct clusters within the snail population, corresponding to "Yunnan North" and "Yunnan South".

CONCLUSIONS

O. h. robertsoni exhibited a relatively high level of genetic differentiation, with variation chiefly existing within snail populations. All snail in this region could be separated into two clusters. The microsatellite loci P82 and P84 might not be suitable for classification studies of O. hupensis in hilly regions. These findings provided important information for the monitoring and control of snail, and for further genetic diversity studies on snail populations.

AZGP1 Aggravates Macrophage M1 Polarization and Pyroptosis in Periodontitis

Periodontal tissue destruction in periodontitis is a consequence of the host inflammatory response to periodontal pathogens, which could be aggravated in the presence of type 2 diabetes mellitus (T2DM). Accumulating evidence highlights the intricate involvement of macrophage-mediated inflammation in the pathogenesis of periodontitis under both normal and T2DM conditions. However, the underlying mechanism remains elusive. Alpha-2-glycoprotein 1 (AZGP1), a glycoprotein featuring an MHC-I domain, has been implicated in both inflammation and metabolic disorders. In this study, we found that AZGP1 was primarily colocalized with macrophages in periodontitis tissues. AZGP1 was increased in periodontitis compared with controls, which was further elevated when accompanied by T2DM. Adeno-associated virus-mediated overexpression of Azgp1 in the periodontium significantly enhanced periodontal inflammation and alveolar bone loss, accompanied by elevated M1 macrophages and pyroptosis in murine models of periodontitis and T2DM-associated periodontitis, while Azgp1-/- mice exhibited opposite effects. In primary bone marrow-derived macrophages stimulated by lipopolysaccharide (LPS) or LPS and palmitic acid (PA), overexpression or knockout of Azgp1 markedly upregulated or suppressed, respectively, the expression of macrophage M1 markers and key components of the NLR Family Pyrin Domain Containing 3 (NLRP3)/caspase-1 signaling. Moreover, conditioned medium from Azgp1-overexpressed macrophages under LPS or LPS+PA stimulation induced higher inflammatory activation and lower osteogenic differentiation in human periodontal ligament stem cells (hPDLSCs). Furthermore, elevated M1 polarization and pyroptosis in macrophages and associated detrimental effects on hPDLSCs induced by Azgp1 overexpression could be rescued by NLRP3 or caspase-1 inhibition. Collectively, our study elucidated that AZGP1 could aggravate periodontitis by promoting macrophage M1 polarization and pyroptosis through the NLRP3/casapse-1 pathway, which was accentuated in T2DM-associated periodontitis. This finding deepens the understanding of AZGP1 in the pathogenesis of periodontitis and suggests AZGP1 as a crucial link mediating the adverse effects of diabetes on periodontal inflammation.

Unlocking Antibacterial Potential: Key-Site-Based Regulation of Antibacterial Spectrum of Peptides

In the pursuit of combating multidrug-resistant bacteria, antimicrobial peptides (AMPs) have emerged as promising agents; however, their application in clinical settings still presents challenges. Specifically, the exploration of crucial structural parameters that influence the antibacterial spectrum of AMPs and the subsequent development of tailored variants with either broad- or narrow-spectrum characteristics to address diverse clinical therapeutic needs has been overlooked. This study focused on investigating the effects of amino acid sites and hydrophobicity on the peptide's antibacterial spectrum through Ala scanning and fixed-point hydrophobic amino acid substitution techniques. The findings revealed that specific amino acid sites played a pivotal role in determining the antibacterial spectrum of AMPs and confirmed that broadening the spectrum could be achieved only by increasing hydrophobicity at certain positions. In conclusion, this research provided a theoretical basis for future precise regulation of an antimicrobial peptide's spectrum by emphasizing the intricate balance between amino acid sites and hydrophobicity.

Structural insights into the unique pH-responsive characteristics of the anti-TIGIT therapeutic antibody Ociperlimab

TIGIT is mainly expressed on T cells and is an inhibitory checkpoint receptor that binds to its ligand PVR in the tumor microenvironment. Anti-TIGIT monoclonal antibodies (mAbs) such as Ociperlimab and Tiragolumab block the TIGIT-PVR interaction and are in clinical development. However, the molecular blockade mechanism of these mAbs remains elusive. Here, we report the crystal structures of TIGIT in complex with Ociperlimab_Fab and Tiragolumab_Fab revealing that both mAbs bind TIGIT with a large steric clash with PVR. Furthermore, several critical epitopic residues are identified. Interestingly, the binding affinity of Ociperlimab toward TIGIT increases approximately 17-fold when lowering the pH from 7.4 to 6.0. Our structure shows a strong electrostatic interaction between ASP103HCDR3 and HIS76TIGIT explaining the pH-responsive mechanism of Ociperlimab. In contrast, Tiragolumab does not show an acidic pH-dependent binding enhancement. Our results provide valuable information that could help to improve the efficacy of therapeutic antibodies for cancer treatment.

Hsa_circ_0001707 regulates endothelial-mesenchymal transition in esophageal squamous cell carcinoma via miR-203a-3p/Snail2 pathway

Esophageal squamous cell carcinoma (ESCC) is a malignant tumor with high mortality and poor prognosis. Despite intensive research focused on tumor suppression, the 5-year survival rate of ESCC is lower than 15%. Therefore, investigate fundamental mechanisms involved in ESCC is on-demand crucial for diagnostics and developing targeted therapeutic drugs. Circular RNAs (circRNAs), as an emerging class of non-coding RNA, have been elucidated that circRNAs participated in regulating a variety of pathological processes and tumorigenesis. Nevertheless, the functional role of circRNAs in the occurrence and development of ESCC remains unclear. We identify a novel circRNA (hsa_circ_0001707), which was highly expressed in ESCC patients' tissues and cell lines. Furthermore, gain- and loss-of-function assays were performed and found that overexpression of hsa_circ_0001707 significantly promote tumor proliferation, metastasis, and invasion. By functioning as a competing endogenous RNA (ceRNA), the dual-luciferase activity assay verified that hsa_circ_0001707 can endogenously bind with miR-203a-3p and regulate its downstream gene Snail2. Rescue assay further confirms that hsa_circ_0001707 downregulation could partially attenuate the facilitation effect of miR-203a-3p, thereby inhibiting the endothelial-mesenchymal transition (EMT) process of ESCC. Our results suggested that hsa_circ_0001707 play an oncogenic role in the pathogenesis of ESCC, which might be a potential biomarker for diagnostics and targeting therapy.

A Retrospective Matched Comparison Study of Prolonged Seizures in ECT

OBJECTIVE

This study assessed the incidence of and risk factors for prolonged seizures (>180 sec) in electroconvulsive therapy (ECT).

METHOD

In 611 adult patients undergoing 6697 ECT treatments administered over a 2.5-year study period, 29 individuals experienced 42 prolonged seizures. A comparison sample (n = 29) was matched on sex, age, and treatment, and compared on psychiatric and medical diagnoses, as well as current medications. To examine the association between the characteristics and prolonged seizure, conditional logistic regression models or exact McNemar tests were conducted.

RESULTS

Prolonged seizures occurred on average in 1 of every 167 treatments. No specific psychiatric disorders or medical conditions were associated with the prolonged seizure group. Antipsychotic drugs were used in a higher proportion of the comparison group than in the prolonged seizure group, suggesting a protective effect. Atropine was used in a lower proportion of the long seizure group than in the comparison group. No untoward sequelae occurred, and no progression to status epilepticus was observed.

CONCLUSIONS

Prolonged seizures appear to be an uncommon complication of ECT in adults. The characteristics examined in this study suggest limited association of psychotropic medications with prolonged seizures. Treatment of prolonged seizures was straightforward. Prolonged seizures had no impact on the course of treatment. Further exploration of prolonged seizures would enhance the generalizability of the findings from this single site study.

Transferring inpatients between wards drives large nosocomial COVID-19 outbreaks, Wales, 2020-22: a matched case-control study using routine and enhanced surveillance data

BACKGROUND

The role of the hospital environment in the spread of COVID-19 is unclear.

AIM

To measure associations between ward characteristics and outbreak size to inform mitigations.

METHODS

Wards with large (case wards) and small (control wards) outbreaks in three acute hospitals were compared. Cases were healthcare-associated COVID-19 inpatients (positive polymerase chain reaction test ≥8 days post admission). Case wards were adult medical/surgical wards with ≥10 cases within rolling 14-day periods, between April 1st, 2020 and April 30th, 2022. Control wards were equivalents with 2-9 cases. Demographic and laboratory data were extracted from routine surveillance systems. Continuous data were aggregated fortnightly and analysed as binary variables according to median values. Each case ward was compared with two control wards matched on outbreak start date (±14 days) to calculate odds ratios (ORs) and 95% confidence intervals (95% CIs) using univariable and conditional multivariable logistic regression.

FINDINGS

From 170 outbreaks (median: 5 cases; interquartile range: 2-9), 35 case wards were identified. Community admissions were lower in case wards vs control wards (5 vs 10 median admissions; P<0.01, respectively), whereas transfers between wards within the same hospital were higher (58 vs 29 median transfers; P<0.01, respectively). Wards with more transfers in the preceding fortnight were significantly more likely to experience a large outbreak (≥35 vs <35 transfers; adjusted OR: 9.08; 95% CI: 2.5-33).

CONCLUSION

We recommend safely minimizing patient movements, such as by asking clinicians to record the rationale for transfer, to reduce the likelihood of disease transmission.

Prediction of lymph node metastasis in operable cervical cancer using clinical parameters and deep learning with MRI data: a multicentre study

OBJECTIVES

To develop and validate a magnetic resonance imaging-based (MRI) deep multiple instance learning (D-MIL) model and combine it with clinical parameters for preoperative prediction of lymph node metastasis (LNM) in operable cervical cancer.

METHODS

A total of 392 patients with cervical cancer were retrospectively enrolled. Clinical parameters were analysed by logistical regression to construct a clinical model (M1). A ResNet50 structure is applied to extract features at the instance level without using manual annotations about the tumour region and then construct a D-MIL model (M2). A hybrid model (M3) was constructed by M1 and M2 scores. The diagnostic performance of each model was evaluated by the area under the receiver operating characteristic curve (AUC) and compared using the Delong method. Disease-free survival (DFS) was evaluated by the Kaplan‒Meier method.

RESULTS

SCC-Ag, maximum lymph node short diameter (LNmax), and tumour volume were found to be independent predictors of M1 model. For the diagnosis of LNM, the AUC of the training/internal/external cohort of M1 was 0.736/0.690/0.732, the AUC of the training/internal/external cohort of M2 was 0.757/0.714/0.765, and the AUC of the training/internal/external cohort of M3 was 0.838/0.764/0.835. M3 showed better performance than M1 and M2. Through the survival analysis, patients with higher hybrid model scores had a shorter time to reach DFS.

CONCLUSION

The proposed hybrid model could be used as a personalised non-invasive tool, which is helpful for predicting LNM in operable cervical cancer. The score of the hybrid model could also reflect the DFS of operable cervical cancer.

CRITICAL RELEVANCE STATEMENT

Lymph node metastasis is an important factor affecting the prognosis of cervical cancer. Preoperative prediction of lymph node status is helpful to make treatment decisions, improve prognosis, and prolong survival time.

KEY POINTS

• The MRI-based deep-learning model can predict the LNM in operable cervical cancer. • The hybrid model has the highest diagnostic efficiency for the LNM prediction. • The score of the hybrid model can reflect the DFS of operable cervical cancer.

Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels the molecular feature of M2 macrophages of head and neck squamous cell carcinoma

The connection between head and neck squamous cell carcinoma (HNSC) and M2 tumour-associated macrophages is not yet fully understood. We gathered gene expression profiles and clinical data from HNSC patients in the TCGA database. Using Consensus Clustering, we categorized these patients into M2 macrophage-related clusters. We developed a M2 macrophage-related signature (MRS) through statistical analyses. Additionally, we assessed gene expression in HNSC cells using single-cell sequencing data (GSE139324). We identified three distinct M2 macrophage-related clusters in HNSC, each with different prognostic outcomes and immune characteristics. Patients with different MRS profiles exhibited variations in immune infiltration, genetic mutations and prognosis. FCGR2A may play a role in creating an immunosuppressive tumour microenvironment and could potentially serve as a therapeutic target for HNSC. Our study demonstrated that M2 macrophage-related genes significantly impact the development and progression of HNSC. The M2 macrophage-related model offered a more comprehensive assessment of HNSC patient prognosis, genetic mutations and immune features. FCGR2A was implicated in immunosuppressive microenvironments and may hold promise for the development of novel immunotherapeutic strategies for HNSC.

A new perspective on gut-lung axis affected through resident microbiome and their implications on immune response in respiratory diseases

The highly diverse microbial ecosystem of the human body colonizes the gastrointestinal tract has a profound impact on the host's immune, metabolic, endocrine, and other physiological processes, which are all interconnected. Specifically, gut microbiota has been found to play a crucial role in facilitating the adaptation and initiation of immune regulatory response through the gastrointestinal tract affecting the other distal mucosal sites such as lungs. A tightly regulated lung-gut axis during respiratory ailments may influence the various molecular patterns that instructs priming the disease severity to dysregulate the normal function. This review provides a comprehensive summary of current research on gut microbiota dysbiosis in respiratory diseases including asthma, pneumonia, bronchopneumonia, COPD during infections and cancer. A complex-interaction among gut microbiome, associated metabolites, cytokines, and chemokines regulates the protective immune response activating the mucosal humoral and cellular response. This potential mechanism bridges the regulation patterns through the gut-lung axis. This paper aims to advance the understanding of the crosstalk of gut-lung microbiome during infection, could lead to strategize to modulate the gut microbiome as a treatment plan to improve bad prognosis in various respiratory diseases.

Cancer-Related Fatigue and Its Influencing Factors Among Colorectal Cancer Patients: A Generalized Linear Modeling Approach

Purpose

This study aimed to improve cancer-related fatigue (CRF) and health outcomes of colorectal cancer patients by understanding the status quo of CRF, exploring the relations of coping, anxiety symptoms, depressive symptoms, body image perception and CRF, and also identifying the factors affecting CRF based on a generalized linear modeling approach.

Patients and Methods

An exploratory cross-sectional study was conducted on 370 colorectal cancer patients at two hospitals in Anhui Province, China, from July 2020 to February 2021. The data were collected by using general information questionnaire, cancer fatigue scale, simplified coping style questionnaire, generalized anxiety disorder-7 scale, patient health questionnaire-9, and body image scale. Descriptive statistics, t-tests, one-way analysis of variance, Pearson correlation analyses, and generalized linear model analyses were applied to analyze the data.

Results

The average CRF score of the patients was 21.612 (SD=6.160), with a prevalence rate of 69.4% for clinically relevant fatigue. The generalized linear model revealed that: In step 1, gender (female) (B=1.799, Waldχ2=7.506, p=0.006), per capita monthly income (1001-3000 RMB) (B=-1.673, Waldχ2=5.536, p=0.019) and treatment modalities (chemotherapy+others) (B=2.425, Waldχ2=8.211, p=0.004) were related to CRF. In step 2, depressive symptoms (B=1.223, Waldχ2=129.019, p<0.001) and negative coping strategies (B=0.215, Waldχ2=11.347, p=0.001) exhibited significant positive correlations with CRF, positive coping strategies (B=-0.319, Waldχ2=59.175, p<0.001) showed significant negative correlations with CRF; While anxiety symptoms (B=0.162, Waldχ2=1.840, p=0.175) and body image perception (B=0.013, Waldχ2=0.048, p=0.826) had no correlations with CRF.

Conclusion

The prevalence of CRF was relatively high among colorectal cancer patients. Coping and depressive symptoms were the modifiable influencing factors of CRF. Tailored interventions dedicated to promoting positive coping behavior, diminishing negative coping behavior and reducing depressive symptoms may improve the CRF of patients with colorectal cancer. Healthcare providers working with these patients should receive corresponding education and training in these complementary treatments. Additionally, when developing non-pharmacological interventions, appropriate consideration of the patients' gender, income condition and the type of anticancer treatment is also necessary.

[Evaluation of the efficacy and safety of intravenous infusion of ferric derisomaltose in the treatment of iron deficiency anemia: a single-center retrospective analysis]

Objective: To investigate the clinical efficacy and safety of ferric derisomaltose injection versus iron sucrose injection in the treatment of iron deficiency anemia (IDA) . Methods: A total of 120 patients with iron deficiency anemia admitted from June 2021 to March 2023 were given intravenous iron supplementation with ferric derisomaltose to assess the efficacy and safety of hemoglobin (HGB) elevation before and after treatment. Simultaneously, the clinical effects of iron supplementation with iron sucrose were compared to those of inpatient patients during the same period. Results: Baseline values were comparable in both groups. Within 12 weeks of treatment, the elevated HGB level in the ferric derisomaltose group was higher than that of the iron sucrose group, with a statistical difference at all time points, and the proportion of HGB increased over 20 g/L in the patients treated for 4 weeks was higher (98.7%, 75.9% ). During the treatment with ferric derisomaltose and iron sucrose, the proportion of mild adverse reactions in the ferric derisomaltose group was slightly lower than that of the iron sucrose group, and neither group experienced any serious adverse reactions. The patients responded well to the infusion treatment, with no reports of pain or pigmentation at the injection site. Conclusion: The treatment of IDA patients with ferric derisomaltose has a satisfactory curative effect, with the advantages of rapidity, accuracy, and safety. Therefore, it is worthy of widespread clinical use.

Is managerial ability a catalyst for driving digital transformation in enterprises? An empirical analysis from internal and external pressure perspectives

In a dynamic and competitive business environment, managerial ability emerges as a pivotal strategic factor for capitalizing on new opportunities within the technological revolution and digital transformation of enterprises. Based on data from Chinese A-share listed firms spanning from 2009 to 2019, this study integrates insights from the upper echelons theory and the behavioral theory of the firm to investigate the moderating roles of historical aspiration shortfalls and industrial competitiveness on the relationship between managerial ability and enterprise digital transformation from internal and external pressure perspectives. Our findings indicate a positive impact of managerial ability on digital transformation. The relationship between managerial ability and digital transformation is reinforced by historical aspiration shortfalls; nevertheless, industrial competitiveness has attenuated the aforementioned relationship. This study contributes to a better understanding of the strategic implications of managerial ability within the context of organizational innovation strategies. It offers valuable insights into the decision-making processes of firms as they navigate the challenges of digital transformation within an ever-evolving business environment.

Development of terpenoid repellents against Aedes albopictus: a combined study of biological activity evaluation and computational modelling

To explore novel terpenoid repellents, 22 candidate terpenoid derivatives were synthesized and tested for their electroantennogram (EAG) responses and repellent activities against Aedes albopictus. The results from the EAG experiments revealed that 5-(2-hydroxypropan-2-yl)-2-methylcyclohex-2-en-1-yl formate (compound 1) induced distinct EAG responses in female Aedes albopictus. At concentrations of 0.1, 1, 10, 100, and 1000 mg/L, the EAG response values for compound 1 were 179.59, 183.99, 190.38, 193.80, and 196.66 mV, demonstrating comparable or superior effectiveness to DEET. Repellent activity analysis indicated significant repellent activity for compound 1, closest to the positive control DEET. The in silico assessment of the ADMET profile of compound 1 indicates that it successfully passed the ADMET evaluation. Molecular docking studies exhibited favourable binding of compound 1 to the active site of the odorant binding protein (OBP) of Aedes albopictus, involving hydrophobic forces and hydrogen bond interactions with residues in the OBP pocket. The QSAR model highlighted the influential role of hydrogen-bonding receptors, positively charged surface area of weighted atoms, polarity parameters of molecules, and maximum nuclear-nuclear repulsion force of carbon-carbon bonds on the relative EAG response values of the tested compounds. This study holds substantial significance for the advancement of new terpenoid repellents.

Effects of combined exposure to polystyrene microplastics and 17α-Methyltestosterone on the reproductive system of zebrafish

Polystyrene microplastics (PS-MPs) are important carriers of pollutants in water. 17α-Methyltestosterone (MT) is a synthetic environmental endocrine disrupting chemical (EDC) with androgenic effects. To study the effects of PS-MPs and MT on zebrafish reproductive systems, zebrafish were exposed to 0 or 50 ng L-1 MT, 0.5 mg∙L-1 PS-MPs, or 50 ng∙L-1 MT + 0.5 mg∙L-1 PS-MPs for 21 d. The results showed that the different exposure reagents caused varying degrees of damage to the reproductive systems in zebrafish, with the extent of damage increasing as the exposure duration increased. Histological analysis of the gonads revealed that the ratio of mature oocytes and mature spermatozoa in the gonad decreased gradually with increased exposure time, with the ratio being Control > PS-MPs > MT > MT + PS-MPs in decreasing order. The results of quantitative real-time PCR (qRT‒PCR) showed that in female fish treated for 7 d, the expression of cyp11a mRNA was significantly reduced in all three treatment groups(MT, PS-MPs, and MT + PS-MPs), while in the group treated for 14 d with MT + PS-MPs, the expression of cyp19a1a and StAR mRNA was significantly increased. In male fish exposed for 21 d, the expression of cyp11a, cyp17a1, cyp19a1a, StAR, 3β-HSD, and 17β-HSD3 mRNA was significantly decreased in MT + PS-MPs. ELISA results showed that after 14 d of exposure, the levels of E2, LH, and FSH in the ovaries of female fish were significantly reduced in all three treatment groups. Similarly, the levels of T, E2, LH, and FSH in the testis of male fish were significantly reduced after 14 d of exposure to PS-MPs and MT + PS-MPs. Offspring of zebrafish exposed to MT and MT + PS-MPs exhibited delayed incubation time and slow development. The cross-generational toxicity of PS-MPs themselves may be negligible, but it can exacerbate the toxicity of MT, making the cross-generational effects more pronounced in the offspring, causing offspring mortality and malformations. Offspring of zebrafish exposed to MT and MT + PS-MPs exhibited delayed incubation time and slow development. In addition, MT caused malformations such as pericardial edema, yolk cysts, and spinal deformities in zebrafish during the incubation period.

Alteration in cartilage matrix stiffness as an indicator and modulator of osteoarthritis

Osteoarthritis (OA) is characterized by cartilage degeneration and destruction, leading to joint ankylosis and disability. The major challenge in diagnosing OA at early stage is not only lack of clinical symptoms but also the insufficient histological and immunohistochemical signs. Alteration in cartilage stiffness during OA progression, especially at OA initiation, has been confirmed by growing evidences. Moreover, the stiffness of cartilage extracellular matrix (ECM), pericellular matrix (PCM) and chondrocytes during OA development are dynamically changed in unique and distinct fashions, revealing possibly inconsistent conclusions when detecting cartilage matrix stiffness at different locations and scales. In addition, it will be discussed regarding the mechanisms through which OA-related cartilage degenerations exhibit stiffened or softened matrix, highlighting some critical events that generally incurred to cartilage stiffness alteration, as well as some typical molecules that participated in constituting the mechanical properties of cartilage. Finally, in vitro culturing chondrocytes in various stiffness-tunable scaffolds provided a reliable method to explore the matrix stiffness-dependent modulation of chondrocyte metabolism, which offers valuable information on optimizing implant scaffolds to maximally promote cartilage repair and regeneration during OA. Overall, this review systematically and comprehensively elucidated the current progresses in the relationship between cartilage stiffness alteration and OA progression. We hope that deeper attention and understanding in this researching field will not only develop more innovative methods in OA early detection and diagnose but also provide promising ideas in OA therapy and prognosis.

ψ(2S) Suppression in Pb-Pb Collisions at the LHC

The production of the ψ(2S) charmonium state was measured with ALICE in Pb-Pb collisions at sqrt[s_{NN}]=5.02  TeV, in the dimuon decay channel. A significant signal was observed for the first time at LHC energies down to zero transverse momentum, at forward rapidity (2.5 Collapse

Key Words Collapse

MESH Headings Collapse

Grants Collapse

Affiliation(s)

S Acharya Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
D Adamová Nuclear Physics Institute of the Czech Academy of Sciences, Husinec-Řež, Czech Republic
A Adler Johann-Wolfgang-Goethe Universität Frankfurt Institut für Informatik, Fachbereich Informatik und Mathematik, Frankfurt, Germany
G Aglieri Rinella European Organization for Nuclear Research (CERN), Geneva, Switzerland
M Agnello Dipartimento DISAT del Politecnico and Sezione INFN, Turin, Italy
N Agrawal INFN, Sezione di Bologna, Bologna, Italy
Z Ahammed Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
S Ahmad Department of Physics, Aligarh Muslim University, Aligarh, India
S U Ahn Korea Institute of Science and Technology Information, Daejeon, Republic of Korea
I Ahuja Faculty of Science, P.J. Šafárik University, Košice, Slovak Republic
A Akindinov Affiliated with an institute covered by a cooperation agreement with CERN
M Al-Turany Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
D Aleksandrov Affiliated with an institute covered by a cooperation agreement with CERN
B Alessandro INFN, Sezione di Torino, Turin, Italy
H M Alfanda Central China Normal University, Wuhan, China
R Alfaro Molina Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
B Ali Department of Physics, Aligarh Muslim University, Aligarh, India
A Alici Dipartimento di Fisica e Astronomia dell'Università and Sezione INFN, Bologna, Italy
N Alizadehvandchali University of Houston, Houston, Texas, USA
A Alkin European Organization for Nuclear Research (CERN), Geneva, Switzerland
J Alme Department of Physics and Technology, University of Bergen, Bergen, Norway
G Alocco INFN, Sezione di Cagliari, Cagliari, Italy
T Alt Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
I Altsybeev Affiliated with an institute covered by a cooperation agreement with CERN
M N Anaam Central China Normal University, Wuhan, China
C Andrei Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest, Romania
A Andronic Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Munster, Germany
V Anguelov Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
F Antinori INFN, Sezione di Padova, Padova, Italy
P Antonioli INFN, Sezione di Bologna, Bologna, Italy
N Apadula Lawrence Berkeley National Laboratory, Berkeley, California, USA
L Aphecetche SUBATECH, IMT Atlantique, Nantes Université, CNRS-IN2P3, Nantes, France
H Appelshäuser Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
C Arata Laboratoire de Physique Subatomique et de Cosmologie, Université Grenoble-Alpes, CNRS-IN2P3, Grenoble, France
S Arcelli Dipartimento di Fisica e Astronomia dell'Università and Sezione INFN, Bologna, Italy
M Aresti INFN, Sezione di Cagliari, Cagliari, Italy
R Arnaldi INFN, Sezione di Torino, Turin, Italy
I C Arsene Department of Physics, University of Oslo, Oslo, Norway
M Arslandok Yale University, New Haven, Connecticut, USA
A Augustinus European Organization for Nuclear Research (CERN), Geneva, Switzerland
R Averbeck Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
M D Azmi Department of Physics, Aligarh Muslim University, Aligarh, India
A Badalà INFN, Sezione di Catania, Catania, Italy
J Bae Sungkyunkwan University, Suwon City, Republic of Korea
Y W Baek Gangneung-Wonju National University, Gangneung, Republic of Korea
X Bai University of Science and Technology of China, Hefei, China
R Bailhache Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
Y Bailung Indian Institute of Technology Indore, Indore, India
A Balbino Dipartimento DISAT del Politecnico and Sezione INFN, Turin, Italy
A Baldisseri Université Paris-Saclay Centre d'Etudes de Saclay (CEA), IRFU, Départment de Physique Nucléaire (DPhN), Saclay, France
B Balis AGH University of Science and Technology, Cracow, Poland
D Banerjee Bose Institute, Department of Physics, and Centre for Astroparticle Physics and Space Science (CAPSS), Kolkata, India
Z Banoo Physics Department, University of Jammu, Jammu, India
R Barbera Dipartimento di Fisica e Astronomia dell'Università and Sezione INFN, Catania, Italy
F Barile Dipartimento Interateneo di Fisica 'M. Merlin' and Sezione INFN, Bari, Italy
L Barioglio Physik Department, Technische Universität München, Munich, Germany
M Barlou National and Kapodistrian University of Athens, School of Science, Department of Physics, Athens, Greece
G G Barnaföldi Wigner Research Centre for Physics, Budapest, Hungary
L S Barnby Nuclear Physics Group, STFC Daresbury Laboratory, Daresbury, United Kingdom
V Barret Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
L Barreto Universidade de São Paulo (USP), São Paulo, Brazil
C Bartels University of Liverpool, Liverpool, United Kingdom
K Barth European Organization for Nuclear Research (CERN), Geneva, Switzerland
E Bartsch Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
F Baruffaldi Dipartimento di Fisica e Astronomia dell'Università and Sezione INFN, Padova, Italy
N Bastid Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
S Basu Lund University Department of Physics, Division of Particle Physics, Lund, Sweden
G Batigne SUBATECH, IMT Atlantique, Nantes Université, CNRS-IN2P3, Nantes, France
D Battistini Physik Department, Technische Universität München, Munich, Germany
B Batyunya Affiliated with an international laboratory covered by a cooperation agreement with CERN
D Bauri Indian Institute of Technology Bombay (IIT), Mumbai, India
J L Bazo Alba Sección Física, Departamento de Ciencias, Pontificia Universidad Católica del Perú, Lima, Peru
I G Bearden Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
C Beattie Yale University, New Haven, Connecticut, USA
P Becht Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
D Behera Indian Institute of Technology Indore, Indore, India
I Belikov Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France, Strasbourg, France
A D C Bell Hechavarria Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Munster, Germany
F Bellini Dipartimento di Fisica e Astronomia dell'Università and Sezione INFN, Bologna, Italy
R Bellwied University of Houston, Houston, Texas, USA
S Belokurova Affiliated with an institute covered by a cooperation agreement with CERN
V Belyaev Affiliated with an institute covered by a cooperation agreement with CERN
G Bencedi Wigner Research Centre for Physics, Budapest, Hungary
S Beole Dipartimento di Fisica dell'Università and Sezione INFN, Turin, Italy
A Bercuci Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest, Romania
Y Berdnikov Affiliated with an institute covered by a cooperation agreement with CERN
A Berdnikova Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
L Bergmann Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
M G Besoiu Institute of Space Science (ISS), Bucharest, Romania
L Betev European Organization for Nuclear Research (CERN), Geneva, Switzerland
P P Bhaduri Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
A Bhasin Physics Department, University of Jammu, Jammu, India
M A Bhat Bose Institute, Department of Physics, and Centre for Astroparticle Physics and Space Science (CAPSS), Kolkata, India
B Bhattacharjee Gauhati University, Department of Physics, Guwahati, India
L Bianchi Dipartimento di Fisica dell'Università and Sezione INFN, Turin, Italy
N Bianchi INFN, Laboratori Nazionali di Frascati, Frascati, Italy
J Bielčík Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech Republic
J Bielčíková Nuclear Physics Institute of the Czech Academy of Sciences, Husinec-Řež, Czech Republic
J Biernat The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
A P Bigot Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France, Strasbourg, France
A Bilandzic Physik Department, Technische Universität München, Munich, Germany
G Biro Wigner Research Centre for Physics, Budapest, Hungary
S Biswas Bose Institute, Department of Physics, and Centre for Astroparticle Physics and Space Science (CAPSS), Kolkata, India
N Bize SUBATECH, IMT Atlantique, Nantes Université, CNRS-IN2P3, Nantes, France
J T Blair The University of Texas at Austin, Austin, Texas, USA
D Blau Affiliated with an institute covered by a cooperation agreement with CERN
M B Blidaru Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
N Bluhme Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
C Blume Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
G Boca Dipartimento di Fisica, Università di Pavia, Pavia, Italy INFN, Sezione di Pavia, Pavia, Italy
F Bock Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA
T Bodova Department of Physics and Technology, University of Bergen, Bergen, Norway
A Bogdanov Affiliated with an institute covered by a cooperation agreement with CERN
S Boi Dipartimento di Fisica dell'Università and Sezione INFN, Cagliari, Italy
J Bok Inha University, Incheon, Republic of Korea
L Boldizsár Wigner Research Centre for Physics, Budapest, Hungary
A Bolozdynya Affiliated with an institute covered by a cooperation agreement with CERN
M Bombara Faculty of Science, P.J. Šafárik University, Košice, Slovak Republic
P M Bond European Organization for Nuclear Research (CERN), Geneva, Switzerland
G Bonomi INFN, Sezione di Pavia, Pavia, Italy Università di Brescia, Brescia, Italy
H Borel Université Paris-Saclay Centre d'Etudes de Saclay (CEA), IRFU, Départment de Physique Nucléaire (DPhN), Saclay, France
A Borissov Affiliated with an institute covered by a cooperation agreement with CERN
A G Borquez Carcamo Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
H Bossi Yale University, New Haven, Connecticut, USA
E Botta Dipartimento di Fisica dell'Università and Sezione INFN, Turin, Italy
Y E M Bouziani Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
L Bratrud Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
P Braun-Munzinger Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
M Bregant Universidade de São Paulo (USP), São Paulo, Brazil
M Broz Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech Republic
G E Bruno Dipartimento Interateneo di Fisica 'M. Merlin' and Sezione INFN, Bari, Italy Politecnico di Bari and Sezione INFN, Bari, Italy
D Budnikov Affiliated with an institute covered by a cooperation agreement with CERN
H Buesching Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
S Bufalino Dipartimento DISAT del Politecnico and Sezione INFN, Turin, Italy
O Bugnon SUBATECH, IMT Atlantique, Nantes Université, CNRS-IN2P3, Nantes, France
P Buhler Stefan Meyer Institut für Subatomare Physik (SMI), Vienna, Austria
Z Buthelezi iThemba LABS, National Research Foundation, Somerset West, South Africa University of the Witwatersrand, Johannesburg, South Africa
S A Bysiak The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
M Cai Central China Normal University, Wuhan, China
H Caines Yale University, New Haven, Connecticut, USA
A Caliva Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
E Calvo Villar Sección Física, Departamento de Ciencias, Pontificia Universidad Católica del Perú, Lima, Peru
J M M Camacho Universidad Autónoma de Sinaloa, Culiacan, Mexico
P Camerini Dipartimento di Fisica dell'Università and Sezione INFN, Trieste, Italy
F D M Canedo Universidade de São Paulo (USP), São Paulo, Brazil
M Carabas University Politehnica of Bucharest, Bucharest, Romania
A A Carballo European Organization for Nuclear Research (CERN), Geneva, Switzerland
F Carnesecchi European Organization for Nuclear Research (CERN), Geneva, Switzerland
R Caron Université de Lyon, CNRS/IN2P3, Institut de Physique des 2 Infinis de Lyon, Lyon, France
J Castillo Castellanos Université Paris-Saclay Centre d'Etudes de Saclay (CEA), IRFU, Départment de Physique Nucléaire (DPhN), Saclay, France
F Catalano Dipartimento di Fisica dell'Università and Sezione INFN, Turin, Italy Dipartimento DISAT del Politecnico and Sezione INFN, Turin, Italy
C Ceballos Sanchez Affiliated with an international laboratory covered by a cooperation agreement with CERN
I Chakaberia Lawrence Berkeley National Laboratory, Berkeley, California, USA
P Chakraborty Indian Institute of Technology Bombay (IIT), Mumbai, India
S Chandra Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
S Chapeland European Organization for Nuclear Research (CERN), Geneva, Switzerland
M Chartier University of Liverpool, Liverpool, United Kingdom
S Chattopadhyay Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
S Chattopadhyay Saha Institute of Nuclear Physics, Homi Bhabha National Institute, Kolkata, India
T G Chavez High Energy Physics Group, Universidad Autónoma de Puebla, Puebla, Mexico
T Cheng Central China Normal University, Wuhan, China Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
C Cheshkov Université de Lyon, CNRS/IN2P3, Institut de Physique des 2 Infinis de Lyon, Lyon, France
B Cheynis Université de Lyon, CNRS/IN2P3, Institut de Physique des 2 Infinis de Lyon, Lyon, France
V Chibante Barroso European Organization for Nuclear Research (CERN), Geneva, Switzerland
D D Chinellato Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil
E S Chizzali Physik Department, Technische Universität München, Munich, Germany
J Cho Inha University, Incheon, Republic of Korea
S Cho Inha University, Incheon, Republic of Korea
P Chochula European Organization for Nuclear Research (CERN), Geneva, Switzerland
P Christakoglou Nikhef, National institute for subatomic physics, Amsterdam, Netherlands
C H Christensen Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
P Christiansen Lund University Department of Physics, Division of Particle Physics, Lund, Sweden
T Chujo University of Tsukuba, Tsukuba, Japan
M Ciacco Dipartimento DISAT del Politecnico and Sezione INFN, Turin, Italy
C Cicalo INFN, Sezione di Cagliari, Cagliari, Italy
F Cindolo INFN, Sezione di Bologna, Bologna, Italy
M R Ciupek Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
G Clai INFN, Sezione di Bologna, Bologna, Italy
F Colamaria INFN, Sezione di Bari, Bari, Italy
J S Colburn School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
D Colella Dipartimento Interateneo di Fisica 'M. Merlin' and Sezione INFN, Bari, Italy Politecnico di Bari and Sezione INFN, Bari, Italy
M Colocci European Organization for Nuclear Research (CERN), Geneva, Switzerland
M Concas INFN, Sezione di Torino, Turin, Italy
G Conesa Balbastre Laboratoire de Physique Subatomique et de Cosmologie, Université Grenoble-Alpes, CNRS-IN2P3, Grenoble, France
Z Conesa Del Valle Laboratoire de Physique des 2 Infinis, Irène Joliot-Curie, Orsay, France
G Contin Dipartimento di Fisica dell'Università and Sezione INFN, Trieste, Italy
J G Contreras Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech Republic
M L Coquet Université Paris-Saclay Centre d'Etudes de Saclay (CEA), IRFU, Départment de Physique Nucléaire (DPhN), Saclay, France
T M Cormier Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA
P Cortese INFN, Sezione di Torino, Turin, Italy Università del Piemonte Orientale, Vercelli, Italy
M R Cosentino Universidade Federal do ABC, Santo Andre, Brazil
F Costa European Organization for Nuclear Research (CERN), Geneva, Switzerland
S Costanza Dipartimento di Fisica, Università di Pavia, Pavia, Italy INFN, Sezione di Pavia, Pavia, Italy
J Crkovská Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
P Crochet Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
R Cruz-Torres Lawrence Berkeley National Laboratory, Berkeley, California, USA
E Cuautle Instituto de Ciencias Nucleares, Universidad Nacional Autónoma de México, Mexico City, Mexico
P Cui Central China Normal University, Wuhan, China
A Dainese INFN, Sezione di Padova, Padova, Italy
M C Danisch Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
A Danu Institute of Space Science (ISS), Bucharest, Romania
P Das National Institute of Science Education and Research, Homi Bhabha National Institute, Jatni, India
P Das Bose Institute, Department of Physics, and Centre for Astroparticle Physics and Space Science (CAPSS), Kolkata, India
S Das Bose Institute, Department of Physics, and Centre for Astroparticle Physics and Space Science (CAPSS), Kolkata, India
A R Dash Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Munster, Germany
S Dash Indian Institute of Technology Bombay (IIT), Mumbai, India
A De Caro Dipartimento di Fisica 'E.R. Caianiello' dell' Università and Gruppo Collegato INFN, Salerno, Italy
G de Cataldo INFN, Sezione di Bari, Bari, Italy
J de Cuveland Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
A De Falco Dipartimento di Fisica dell'Università and Sezione INFN, Cagliari, Italy
D De Gruttola Dipartimento di Fisica 'E.R. Caianiello' dell' Università and Gruppo Collegato INFN, Salerno, Italy
N De Marco INFN, Sezione di Torino, Turin, Italy
C De Martin Dipartimento di Fisica dell'Università and Sezione INFN, Trieste, Italy
S De Pasquale Dipartimento di Fisica 'E.R. Caianiello' dell' Università and Gruppo Collegato INFN, Salerno, Italy
S Deb Indian Institute of Technology Indore, Indore, India
R J Debski AGH University of Science and Technology, Cracow, Poland
K R Deja Warsaw University of Technology, Warsaw, Poland
R Del Grande Physik Department, Technische Universität München, Munich, Germany
L Dello Stritto Dipartimento di Fisica 'E.R. Caianiello' dell' Università and Gruppo Collegato INFN, Salerno, Italy
W Deng Central China Normal University, Wuhan, China
P Dhankher Department of Physics, University of California, Berkeley, California, USA
D Di Bari Dipartimento Interateneo di Fisica 'M. Merlin' and Sezione INFN, Bari, Italy
A Di Mauro European Organization for Nuclear Research (CERN), Geneva, Switzerland
R A Diaz Centro de Aplicaciones Tecnológicas y Desarrollo Nuclear (CEADEN), Havana, Cuba Affiliated with an international laboratory covered by a cooperation agreement with CERN
T Dietel University of Cape Town, Cape Town, South Africa
Y Ding Central China Normal University, Wuhan, China Université de Lyon, CNRS/IN2P3, Institut de Physique des 2 Infinis de Lyon, Lyon, France
R Divià European Organization for Nuclear Research (CERN), Geneva, Switzerland
D U Dixit Department of Physics, University of California, Berkeley, California, USA
Ø Djuvsland Department of Physics and Technology, University of Bergen, Bergen, Norway
U Dmitrieva Affiliated with an institute covered by a cooperation agreement with CERN
A Dobrin Institute of Space Science (ISS), Bucharest, Romania
B Dönigus Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
J M Dubinski Warsaw University of Technology, Warsaw, Poland
A Dubla Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
S Dudi Physics Department, Panjab University, Chandigarh, India
P Dupieux Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
M Durkac Technical University of Košice, Košice, Slovak Republic
N Dzalaiova Comenius University Bratislava, Faculty of Mathematics, Physics and Informatics, Bratislava, Slovak Republic
T M Eder Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Munster, Germany
R J Ehlers Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA
V N Eikeland Department of Physics and Technology, University of Bergen, Bergen, Norway
F Eisenhut Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
D Elia INFN, Sezione di Bari, Bari, Italy
B Erazmus SUBATECH, IMT Atlantique, Nantes Université, CNRS-IN2P3, Nantes, France
F Ercolessi Dipartimento di Fisica e Astronomia dell'Università and Sezione INFN, Bologna, Italy
F Erhardt Physics department, Faculty of science, University of Zagreb, Zagreb, Croatia
M R Ersdal Department of Physics and Technology, University of Bergen, Bergen, Norway
B Espagnon Laboratoire de Physique des 2 Infinis, Irène Joliot-Curie, Orsay, France
G Eulisse European Organization for Nuclear Research (CERN), Geneva, Switzerland
D Evans School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
S Evdokimov Affiliated with an institute covered by a cooperation agreement with CERN
L Fabbietti Physik Department, Technische Universität München, Munich, Germany
M Faggin Dipartimento di Fisica e Astronomia dell'Università and Sezione INFN, Padova, Italy
J Faivre Laboratoire de Physique Subatomique et de Cosmologie, Université Grenoble-Alpes, CNRS-IN2P3, Grenoble, France
F Fan Central China Normal University, Wuhan, China
W Fan Lawrence Berkeley National Laboratory, Berkeley, California, USA
A Fantoni INFN, Laboratori Nazionali di Frascati, Frascati, Italy
M Fasel Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA
P Fecchio Dipartimento DISAT del Politecnico and Sezione INFN, Turin, Italy
A Feliciello INFN, Sezione di Torino, Turin, Italy
G Feofilov Affiliated with an institute covered by a cooperation agreement with CERN
A Fernández Téllez High Energy Physics Group, Universidad Autónoma de Puebla, Puebla, Mexico
L Ferrandi Universidade de São Paulo (USP), São Paulo, Brazil
M B Ferrer European Organization for Nuclear Research (CERN), Geneva, Switzerland
A Ferrero Université Paris-Saclay Centre d'Etudes de Saclay (CEA), IRFU, Départment de Physique Nucléaire (DPhN), Saclay, France
C Ferrero INFN, Sezione di Torino, Turin, Italy
A Ferretti Dipartimento di Fisica dell'Università and Sezione INFN, Turin, Italy
V J G Feuillard Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
V Filova Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech Republic
D Finogeev Affiliated with an institute covered by a cooperation agreement with CERN
F M Fionda INFN, Sezione di Cagliari, Cagliari, Italy
F Flor University of Houston, Houston, Texas, USA
A N Flores The University of Texas at Austin, Austin, Texas, USA
S Foertsch iThemba LABS, National Research Foundation, Somerset West, South Africa
I Fokin Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
S Fokin Affiliated with an institute covered by a cooperation agreement with CERN
E Fragiacomo INFN, Sezione di Trieste, Trieste, Italy
E Frajna Wigner Research Centre for Physics, Budapest, Hungary
U Fuchs European Organization for Nuclear Research (CERN), Geneva, Switzerland
N Funicello Dipartimento di Fisica 'E.R. Caianiello' dell' Università and Gruppo Collegato INFN, Salerno, Italy
C Furget Laboratoire de Physique Subatomique et de Cosmologie, Université Grenoble-Alpes, CNRS-IN2P3, Grenoble, France
A Furs Affiliated with an institute covered by a cooperation agreement with CERN
T Fusayasu Saga University, Saga, Japan
J J Gaardhøje Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
M Gagliardi Dipartimento di Fisica dell'Università and Sezione INFN, Turin, Italy
A M Gago Sección Física, Departamento de Ciencias, Pontificia Universidad Católica del Perú, Lima, Peru
C D Galvan Universidad Autónoma de Sinaloa, Culiacan, Mexico
D R Gangadharan University of Houston, Houston, Texas, USA
P Ganoti National and Kapodistrian University of Athens, School of Science, Department of Physics, Athens, Greece
C Garabatos Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
J R A Garcia High Energy Physics Group, Universidad Autónoma de Puebla, Puebla, Mexico
E Garcia-Solis Chicago State University, Chicago, Illinois, USA
K Garg SUBATECH, IMT Atlantique, Nantes Université, CNRS-IN2P3, Nantes, France
C Gargiulo European Organization for Nuclear Research (CERN), Geneva, Switzerland
A Garibli National Nuclear Research Center, Baku, Azerbaijan
K Garner Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Munster, Germany
P Gasik Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
A Gautam University of Kansas, Lawrence, Kansas, USA
M B Gay Ducati Instituto de Física, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil
M Germain SUBATECH, IMT Atlantique, Nantes Université, CNRS-IN2P3, Nantes, France
C Ghosh Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
M Giacalone Dipartimento di Fisica e Astronomia dell'Università and Sezione INFN, Bologna, Italy
P Giubellino INFN, Sezione di Torino, Turin, Italy Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
P Giubilato Dipartimento di Fisica e Astronomia dell'Università and Sezione INFN, Padova, Italy
A M C Glaenzer Université Paris-Saclay Centre d'Etudes de Saclay (CEA), IRFU, Départment de Physique Nucléaire (DPhN), Saclay, France
P Glässel Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
E Glimos University of Tennessee, Knoxville, Tennessee, USA
D J Q Goh Nagasaki Institute of Applied Science, Nagasaki, Japan
V Gonzalez Wayne State University, Detroit, Michigan, USA
L H González-Trueba Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
M Gorgon AGH University of Science and Technology, Cracow, Poland
S Gotovac Faculty of Electrical Engineering, Mechanical Engineering and Naval Architecture, University of Split, Split, Croatia
V Grabski Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
L K Graczykowski Warsaw University of Technology, Warsaw, Poland
E Grecka Nuclear Physics Institute of the Czech Academy of Sciences, Husinec-Řež, Czech Republic
A Grelli Institute for Gravitational and Subatomic Physics (GRASP), Utrecht University/Nikhef, Utrecht, Netherlands
C Grigoras European Organization for Nuclear Research (CERN), Geneva, Switzerland
V Grigoriev Affiliated with an institute covered by a cooperation agreement with CERN
S Grigoryan A.I. Alikhanyan National Science Laboratory (Yerevan Physics Institute) Foundation, Yerevan, Armenia Affiliated with an international laboratory covered by a cooperation agreement with CERN
F Grosa European Organization for Nuclear Research (CERN), Geneva, Switzerland
J F Grosse-Oetringhaus European Organization for Nuclear Research (CERN), Geneva, Switzerland
R Grosso Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
D Grund Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech Republic
G G Guardiano Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil
R Guernane Laboratoire de Physique Subatomique et de Cosmologie, Université Grenoble-Alpes, CNRS-IN2P3, Grenoble, France
M Guilbaud SUBATECH, IMT Atlantique, Nantes Université, CNRS-IN2P3, Nantes, France
K Gulbrandsen Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
T Gundem Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
T Gunji University of Tokyo, Tokyo, Japan
W Guo Central China Normal University, Wuhan, China
A Gupta Physics Department, University of Jammu, Jammu, India
R Gupta Physics Department, University of Jammu, Jammu, India
S P Guzman High Energy Physics Group, Universidad Autónoma de Puebla, Puebla, Mexico
L Gyulai Wigner Research Centre for Physics, Budapest, Hungary
M K Habib Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
C Hadjidakis Laboratoire de Physique des 2 Infinis, Irène Joliot-Curie, Orsay, France
F U Haider Physics Department, University of Jammu, Jammu, India
H Hamagaki Nagasaki Institute of Applied Science, Nagasaki, Japan
A Hamdi Lawrence Berkeley National Laboratory, Berkeley, California, USA
M Hamid Central China Normal University, Wuhan, China
Y Han Yonsei University, Seoul, Republic of Korea
R Hannigan The University of Texas at Austin, Austin, Texas, USA
M R Haque Warsaw University of Technology, Warsaw, Poland
J W Harris Yale University, New Haven, Connecticut, USA
A Harton Chicago State University, Chicago, Illinois, USA
H Hassan Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA
D Hatzifotiadou INFN, Sezione di Bologna, Bologna, Italy
P Hauer Helmholtz-Institut für Strahlen- und Kernphysik, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany
L B Havener Yale University, New Haven, Connecticut, USA
S T Heckel Physik Department, Technische Universität München, Munich, Germany
E Hellbär Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
H Helstrup Faculty of Engineering and Science, Western Norway University of Applied Sciences, Bergen, Norway
M Hemmer Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
T Herman Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech Republic
G Herrera Corral Centro de Investigación y de Estudios Avanzados (CINVESTAV), Mexico City and Merida, Mexico
F Herrmann Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Munster, Germany
S Herrmann Université de Lyon, CNRS/IN2P3, Institut de Physique des 2 Infinis de Lyon, Lyon, France
K F Hetland Faculty of Engineering and Science, Western Norway University of Applied Sciences, Bergen, Norway
B Heybeck Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
H Hillemanns European Organization for Nuclear Research (CERN), Geneva, Switzerland
C Hills University of Liverpool, Liverpool, United Kingdom
B Hippolyte Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France, Strasbourg, France
B Hofman Institute for Gravitational and Subatomic Physics (GRASP), Utrecht University/Nikhef, Utrecht, Netherlands
B Hohlweger Nikhef, National institute for subatomic physics, Amsterdam, Netherlands
G H Hong Yonsei University, Seoul, Republic of Korea
M Horst Physik Department, Technische Universität München, Munich, Germany
A Horzyk AGH University of Science and Technology, Cracow, Poland
R Hosokawa Creighton University, Omaha, Nebraska, USA
Y Hou Central China Normal University, Wuhan, China
P Hristov European Organization for Nuclear Research (CERN), Geneva, Switzerland
C Hughes University of Tennessee, Knoxville, Tennessee, USA
P Huhn Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
L M Huhta University of Jyväskylä, Jyväskylä, Finland
C V Hulse Laboratoire de Physique des 2 Infinis, Irène Joliot-Curie, Orsay, France
T J Humanic Ohio State University, Columbus, Ohio, USA
H Hushnud Department of Physics, Aligarh Muslim University, Aligarh, India Saha Institute of Nuclear Physics, Homi Bhabha National Institute, Kolkata, India
A Hutson University of Houston, Houston, Texas, USA
D Hutter Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
J P Iddon University of Liverpool, Liverpool, United Kingdom
R Ilkaev Affiliated with an institute covered by a cooperation agreement with CERN
H Ilyas COMSATS University Islamabad, Islamabad, Pakistan
M Inaba University of Tsukuba, Tsukuba, Japan
G M Innocenti European Organization for Nuclear Research (CERN), Geneva, Switzerland
M Ippolitov Affiliated with an institute covered by a cooperation agreement with CERN
A Isakov Nuclear Physics Institute of the Czech Academy of Sciences, Husinec-Řež, Czech Republic
T Isidori University of Kansas, Lawrence, Kansas, USA
M S Islam Saha Institute of Nuclear Physics, Homi Bhabha National Institute, Kolkata, India
M Ivanov Comenius University Bratislava, Faculty of Mathematics, Physics and Informatics, Bratislava, Slovak Republic
M Ivanov Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
V Ivanov Affiliated with an institute covered by a cooperation agreement with CERN
M Jablonski AGH University of Science and Technology, Cracow, Poland
B Jacak Lawrence Berkeley National Laboratory, Berkeley, California, USA
N Jacazio European Organization for Nuclear Research (CERN), Geneva, Switzerland
P M Jacobs Lawrence Berkeley National Laboratory, Berkeley, California, USA
S Jadlovska Technical University of Košice, Košice, Slovak Republic
J Jadlovsky Technical University of Košice, Košice, Slovak Republic
S Jaelani National Research and Innovation Agency - BRIN, Jakarta, Indonesia
L Jaffe Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
C Jahnke Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil
M J Jakubowska Warsaw University of Technology, Warsaw, Poland
M A Janik Warsaw University of Technology, Warsaw, Poland
T Janson Johann-Wolfgang-Goethe Universität Frankfurt Institut für Informatik, Fachbereich Informatik und Mathematik, Frankfurt, Germany
M Jercic Physics department, Faculty of science, University of Zagreb, Zagreb, Croatia
S Jia China Institute of Atomic Energy, Beijing, China
A A P Jimenez Instituto de Ciencias Nucleares, Universidad Nacional Autónoma de México, Mexico City, Mexico
F Jonas Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA
J M Jowett European Organization for Nuclear Research (CERN), Geneva, Switzerland Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
J Jung Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
M Jung Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
A Junique European Organization for Nuclear Research (CERN), Geneva, Switzerland
A Jusko School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
M J Kabus European Organization for Nuclear Research (CERN), Geneva, Switzerland Warsaw University of Technology, Warsaw, Poland
J Kaewjai Suranaree University of Technology, Nakhon Ratchasima, Thailand
P Kalinak Institute of Experimental Physics, Slovak Academy of Sciences, Košice, Slovak Republic
A S Kalteyer Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
A Kalweit European Organization for Nuclear Research (CERN), Geneva, Switzerland
V Kaplin Affiliated with an institute covered by a cooperation agreement with CERN
A Karasu Uysal KTO Karatay University, Konya, Turkey
D Karatovic Physics department, Faculty of science, University of Zagreb, Zagreb, Croatia
O Karavichev Affiliated with an institute covered by a cooperation agreement with CERN
T Karavicheva Affiliated with an institute covered by a cooperation agreement with CERN
P Karczmarczyk Warsaw University of Technology, Warsaw, Poland
E Karpechev Affiliated with an institute covered by a cooperation agreement with CERN
U Kebschull Johann-Wolfgang-Goethe Universität Frankfurt Institut für Informatik, Fachbereich Informatik und Mathematik, Frankfurt, Germany
R Keidel Zentrum für Technologie und Transfer (ZTT), Worms, Germany
D L D Keijdener Institute for Gravitational and Subatomic Physics (GRASP), Utrecht University/Nikhef, Utrecht, Netherlands
M Keil European Organization for Nuclear Research (CERN), Geneva, Switzerland
B Ketzer Helmholtz-Institut für Strahlen- und Kernphysik, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany
A M Khan Central China Normal University, Wuhan, China
S Khan Department of Physics, Aligarh Muslim University, Aligarh, India
A Khanzadeev Affiliated with an institute covered by a cooperation agreement with CERN
Y Kharlov Affiliated with an institute covered by a cooperation agreement with CERN
A Khatun Department of Physics, Aligarh Muslim University, Aligarh, India University of Kansas, Lawrence, Kansas, USA
A Khuntia The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
M B Kidson University of Cape Town, Cape Town, South Africa
B Kileng Faculty of Engineering and Science, Western Norway University of Applied Sciences, Bergen, Norway
B Kim Department of Physics, Pusan National University, Pusan, Republic of Korea
C Kim Department of Physics, Pusan National University, Pusan, Republic of Korea
D J Kim University of Jyväskylä, Jyväskylä, Finland
E J Kim Jeonbuk National University, Jeonju, Republic of Korea
J Kim Yonsei University, Seoul, Republic of Korea
J S Kim Gangneung-Wonju National University, Gangneung, Republic of Korea
J Kim Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
J Kim Jeonbuk National University, Jeonju, Republic of Korea
M Kim Department of Physics, University of California, Berkeley, California, USA Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
S Kim Department of Physics, Sejong University, Seoul, Republic of Korea
T Kim Yonsei University, Seoul, Republic of Korea
K Kimura Physics Program and International Institute for Sustainability with Knotted Chiral Meta Matter (SKCM2), Hiroshima University, Hiroshima, Japan
S Kirsch Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
I Kisel Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
S Kiselev Affiliated with an institute covered by a cooperation agreement with CERN
A Kisiel Warsaw University of Technology, Warsaw, Poland
J P Kitowski AGH University of Science and Technology, Cracow, Poland
J L Klay California Polytechnic State University, San Luis Obispo, California, USA
J Klein European Organization for Nuclear Research (CERN), Geneva, Switzerland
S Klein Lawrence Berkeley National Laboratory, Berkeley, California, USA
C Klein-Bösing Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Munster, Germany
M Kleiner Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
T Klemenz Physik Department, Technische Universität München, Munich, Germany
A Kluge European Organization for Nuclear Research (CERN), Geneva, Switzerland
A G Knospe University of Houston, Houston, Texas, USA
C Kobdaj Suranaree University of Technology, Nakhon Ratchasima, Thailand
T Kollegger Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
A Kondratyev Affiliated with an international laboratory covered by a cooperation agreement with CERN
E Kondratyuk Affiliated with an institute covered by a cooperation agreement with CERN
J Konig Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
S A Konigstorfer Physik Department, Technische Universität München, Munich, Germany
P J Konopka European Organization for Nuclear Research (CERN), Geneva, Switzerland
G Kornakov Warsaw University of Technology, Warsaw, Poland
S D Koryciak AGH University of Science and Technology, Cracow, Poland
A Kotliarov Nuclear Physics Institute of the Czech Academy of Sciences, Husinec-Řež, Czech Republic
V Kovalenko Affiliated with an institute covered by a cooperation agreement with CERN
M Kowalski The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
V Kozhuharov Faculty of Physics, Sofia University, Sofia, Bulgaria
I Králik Institute of Experimental Physics, Slovak Academy of Sciences, Košice, Slovak Republic
A Kravčáková Faculty of Science, P.J. Šafárik University, Košice, Slovak Republic
L Kreis Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
M Krivda Institute of Experimental Physics, Slovak Academy of Sciences, Košice, Slovak Republic School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
F Krizek Nuclear Physics Institute of the Czech Academy of Sciences, Husinec-Řež, Czech Republic
K Krizkova Gajdosova Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech Republic
M Kroesen Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
M Krüger Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
D M Krupova Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech Republic
E Kryshen Affiliated with an institute covered by a cooperation agreement with CERN
V Kučera European Organization for Nuclear Research (CERN), Geneva, Switzerland
C Kuhn Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France, Strasbourg, France
P G Kuijer Nikhef, National institute for subatomic physics, Amsterdam, Netherlands
T Kumaoka University of Tsukuba, Tsukuba, Japan
D Kumar Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
L Kumar Physics Department, Panjab University, Chandigarh, India
N Kumar Physics Department, Panjab University, Chandigarh, India
S Kumar Dipartimento Interateneo di Fisica 'M. Merlin' and Sezione INFN, Bari, Italy
S Kundu European Organization for Nuclear Research (CERN), Geneva, Switzerland
P Kurashvili National Centre for Nuclear Research, Warsaw, Poland
A Kurepin Affiliated with an institute covered by a cooperation agreement with CERN
A B Kurepin Affiliated with an institute covered by a cooperation agreement with CERN
A Kuryakin Affiliated with an institute covered by a cooperation agreement with CERN
S Kushpil Nuclear Physics Institute of the Czech Academy of Sciences, Husinec-Řež, Czech Republic
J Kvapil School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
M J Kweon Inha University, Incheon, Republic of Korea
J Y Kwon Inha University, Incheon, Republic of Korea
Y Kwon Yonsei University, Seoul, Republic of Korea
S L La Pointe Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
P La Rocca Dipartimento di Fisica e Astronomia dell'Università and Sezione INFN, Catania, Italy
Y S Lai Lawrence Berkeley National Laboratory, Berkeley, California, USA
A Lakrathok Suranaree University of Technology, Nakhon Ratchasima, Thailand
M Lamanna European Organization for Nuclear Research (CERN), Geneva, Switzerland
R Langoy University of South-Eastern Norway, Kongsberg, Norway
P Larionov European Organization for Nuclear Research (CERN), Geneva, Switzerland
E Laudi European Organization for Nuclear Research (CERN), Geneva, Switzerland
L Lautner European Organization for Nuclear Research (CERN), Geneva, Switzerland Physik Department, Technische Universität München, Munich, Germany
R Lavicka Stefan Meyer Institut für Subatomare Physik (SMI), Vienna, Austria
T Lazareva Affiliated with an institute covered by a cooperation agreement with CERN
R Lea INFN, Sezione di Pavia, Pavia, Italy Università di Brescia, Brescia, Italy
H Lee Sungkyunkwan University, Suwon City, Republic of Korea
G Legras Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Munster, Germany
J Lehrbach Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
R C Lemmon Nuclear Physics Group, STFC Daresbury Laboratory, Daresbury, United Kingdom
I León Monzón Universidad Autónoma de Sinaloa, Culiacan, Mexico
M M Lesch Physik Department, Technische Universität München, Munich, Germany
E D Lesser Department of Physics, University of California, Berkeley, California, USA
M Lettrich Physik Department, Technische Universität München, Munich, Germany
P Lévai Wigner Research Centre for Physics, Budapest, Hungary
X Li China Institute of Atomic Energy, Beijing, China
X L Li Central China Normal University, Wuhan, China
J Lien University of South-Eastern Norway, Kongsberg, Norway
R Lietava School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
B Lim Department of Physics, Pusan National University, Pusan, Republic of Korea Dipartimento di Fisica dell'Università and Sezione INFN, Turin, Italy
S H Lim Department of Physics, Pusan National University, Pusan, Republic of Korea
V Lindenstruth Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
A Lindner Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest, Romania
C Lippmann Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
A Liu Department of Physics, University of California, Berkeley, California, USA
D H Liu Central China Normal University, Wuhan, China
J Liu University of Liverpool, Liverpool, United Kingdom
I M Lofnes Department of Physics and Technology, University of Bergen, Bergen, Norway
C Loizides Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA
S Lokos The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
P Loncar Faculty of Electrical Engineering, Mechanical Engineering and Naval Architecture, University of Split, Split, Croatia
J A Lopez Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
X Lopez Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
E López Torres Centro de Aplicaciones Tecnológicas y Desarrollo Nuclear (CEADEN), Havana, Cuba
P Lu Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany University of Science and Technology of China, Hefei, China
J R Luhder Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Munster, Germany
M Lunardon Dipartimento di Fisica e Astronomia dell'Università and Sezione INFN, Padova, Italy
G Luparello INFN, Sezione di Trieste, Trieste, Italy
Y G Ma Fudan University, Shanghai, China
A Maevskaya Affiliated with an institute covered by a cooperation agreement with CERN
M Mager European Organization for Nuclear Research (CERN), Geneva, Switzerland
T Mahmoud Helmholtz-Institut für Strahlen- und Kernphysik, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany
A Maire Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France, Strasbourg, France
M V Makariev Faculty of Physics, Sofia University, Sofia, Bulgaria
M Malaev Affiliated with an institute covered by a cooperation agreement with CERN
G Malfattore Dipartimento di Fisica e Astronomia dell'Università and Sezione INFN, Bologna, Italy
N M Malik Physics Department, University of Jammu, Jammu, India
Q W Malik Department of Physics, University of Oslo, Oslo, Norway
S K Malik Physics Department, University of Jammu, Jammu, India
L Malinina Affiliated with an international laboratory covered by a cooperation agreement with CERN
D Mal'Kevich Affiliated with an institute covered by a cooperation agreement with CERN
D Mallick National Institute of Science Education and Research, Homi Bhabha National Institute, Jatni, India
N Mallick Indian Institute of Technology Indore, Indore, India
G Mandaglio Dipartimento di Scienze MIFT, Università di Messina, Messina, Italy INFN, Sezione di Catania, Catania, Italy
V Manko Affiliated with an institute covered by a cooperation agreement with CERN
F Manso Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
V Manzari INFN, Sezione di Bari, Bari, Italy
Y Mao Central China Normal University, Wuhan, China
G V Margagliotti Dipartimento di Fisica dell'Università and Sezione INFN, Trieste, Italy
A Margotti INFN, Sezione di Bologna, Bologna, Italy
A Marín Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
C Markert The University of Texas at Austin, Austin, Texas, USA
P Martinengo European Organization for Nuclear Research (CERN), Geneva, Switzerland
J L Martinez University of Houston, Houston, Texas, USA
M I Martínez High Energy Physics Group, Universidad Autónoma de Puebla, Puebla, Mexico
G Martínez García SUBATECH, IMT Atlantique, Nantes Université, CNRS-IN2P3, Nantes, France
S Masciocchi Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
M Masera Dipartimento di Fisica dell'Università and Sezione INFN, Turin, Italy
A Masoni INFN, Sezione di Cagliari, Cagliari, Italy
L Massacrier Laboratoire de Physique des 2 Infinis, Irène Joliot-Curie, Orsay, France
A Mastroserio INFN, Sezione di Bari, Bari, Italy Università degli Studi di Foggia, Foggia, Italy
A M Mathis Physik Department, Technische Universität München, Munich, Germany
O Matonoha Lund University Department of Physics, Division of Particle Physics, Lund, Sweden
P F T Matuoka Universidade de São Paulo (USP), São Paulo, Brazil
A Matyja The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
C Mayer The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
A L Mazuecos European Organization for Nuclear Research (CERN), Geneva, Switzerland
F Mazzaschi Dipartimento di Fisica dell'Università and Sezione INFN, Turin, Italy
M Mazzilli European Organization for Nuclear Research (CERN), Geneva, Switzerland
J E Mdhluli University of the Witwatersrand, Johannesburg, South Africa
A F Mechler Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
Y Melikyan Helsinki Institute of Physics (HIP), Helsinki, Finland Affiliated with an institute covered by a cooperation agreement with CERN
A Menchaca-Rocha Instituto de Física, Universidad Nacional Autónoma de México, Mexico City, Mexico
E Meninno Dipartimento di Fisica 'E.R. Caianiello' dell' Università and Gruppo Collegato INFN, Salerno, Italy Stefan Meyer Institut für Subatomare Physik (SMI), Vienna, Austria
A S Menon University of Houston, Houston, Texas, USA
M Meres Comenius University Bratislava, Faculty of Mathematics, Physics and Informatics, Bratislava, Slovak Republic
S Mhlanga iThemba LABS, National Research Foundation, Somerset West, South Africa University of Cape Town, Cape Town, South Africa
Y Miake University of Tsukuba, Tsukuba, Japan
L Micheletti INFN, Sezione di Torino, Turin, Italy
L C Migliorin Université de Lyon, CNRS/IN2P3, Institut de Physique des 2 Infinis de Lyon, Lyon, France
D L Mihaylov Physik Department, Technische Universität München, Munich, Germany
K Mikhaylov Affiliated with an institute covered by a cooperation agreement with CERN Affiliated with an international laboratory covered by a cooperation agreement with CERN
A N Mishra Wigner Research Centre for Physics, Budapest, Hungary
D Miśkowiec Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
A Modak Bose Institute, Department of Physics, and Centre for Astroparticle Physics and Space Science (CAPSS), Kolkata, India
A P Mohanty Institute for Gravitational and Subatomic Physics (GRASP), Utrecht University/Nikhef, Utrecht, Netherlands
B Mohanty National Institute of Science Education and Research, Homi Bhabha National Institute, Jatni, India
M Mohisin Khan Department of Physics, Aligarh Muslim University, Aligarh, India
M A Molander Helsinki Institute of Physics (HIP), Helsinki, Finland
Z Moravcova Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
C Mordasini Physik Department, Technische Universität München, Munich, Germany
D A Moreira De Godoy Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Munster, Germany
I Morozov Affiliated with an institute covered by a cooperation agreement with CERN
A Morsch European Organization for Nuclear Research (CERN), Geneva, Switzerland
T Mrnjavac European Organization for Nuclear Research (CERN), Geneva, Switzerland
V Muccifora INFN, Laboratori Nazionali di Frascati, Frascati, Italy
S Muhuri Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
J D Mulligan Lawrence Berkeley National Laboratory, Berkeley, California, USA
A Mulliri Dipartimento di Fisica dell'Università and Sezione INFN, Cagliari, Italy
M G Munhoz Universidade de São Paulo (USP), São Paulo, Brazil
R H Munzer Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
H Murakami University of Tokyo, Tokyo, Japan
S Murray University of Cape Town, Cape Town, South Africa
L Musa European Organization for Nuclear Research (CERN), Geneva, Switzerland
J Musinsky Institute of Experimental Physics, Slovak Academy of Sciences, Košice, Slovak Republic
J W Myrcha Warsaw University of Technology, Warsaw, Poland
B Naik University of the Witwatersrand, Johannesburg, South Africa
A I Nambrath Department of Physics, University of California, Berkeley, California, USA
B K Nandi Indian Institute of Technology Bombay (IIT), Mumbai, India
R Nania INFN, Sezione di Bologna, Bologna, Italy
E Nappi INFN, Sezione di Bari, Bari, Italy
A F Nassirpour Lund University Department of Physics, Division of Particle Physics, Lund, Sweden
A Nath Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
C Nattrass University of Tennessee, Knoxville, Tennessee, USA
M N Naydenov Faculty of Physics, Sofia University, Sofia, Bulgaria
A Neagu Department of Physics, University of Oslo, Oslo, Norway
A Negru University Politehnica of Bucharest, Bucharest, Romania
L Nellen Instituto de Ciencias Nucleares, Universidad Nacional Autónoma de México, Mexico City, Mexico
S V Nesbo Faculty of Engineering and Science, Western Norway University of Applied Sciences, Bergen, Norway
G Neskovic Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
D Nesterov Affiliated with an institute covered by a cooperation agreement with CERN
B S Nielsen Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
E G Nielsen Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
S Nikolaev Affiliated with an institute covered by a cooperation agreement with CERN
S Nikulin Affiliated with an institute covered by a cooperation agreement with CERN
V Nikulin Affiliated with an institute covered by a cooperation agreement with CERN
F Noferini INFN, Sezione di Bologna, Bologna, Italy
S Noh Chungbuk National University, Cheongju, Republic of Korea
P Nomokonov Affiliated with an international laboratory covered by a cooperation agreement with CERN
J Norman University of Liverpool, Liverpool, United Kingdom
N Novitzky University of Tsukuba, Tsukuba, Japan
P Nowakowski Warsaw University of Technology, Warsaw, Poland
A Nyanin Affiliated with an institute covered by a cooperation agreement with CERN
J Nystrand Department of Physics and Technology, University of Bergen, Bergen, Norway
M Ogino Nagasaki Institute of Applied Science, Nagasaki, Japan
A Ohlson Lund University Department of Physics, Division of Particle Physics, Lund, Sweden
V A Okorokov Affiliated with an institute covered by a cooperation agreement with CERN
J Oleniacz Warsaw University of Technology, Warsaw, Poland
A C Oliveira Da Silva University of Tennessee, Knoxville, Tennessee, USA
M H Oliver Yale University, New Haven, Connecticut, USA
A Onnerstad University of Jyväskylä, Jyväskylä, Finland
C Oppedisano INFN, Sezione di Torino, Turin, Italy
A Ortiz Velasquez Instituto de Ciencias Nucleares, Universidad Nacional Autónoma de México, Mexico City, Mexico
J Otwinowski The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
M Oya Physics Program and International Institute for Sustainability with Knotted Chiral Meta Matter (SKCM2), Hiroshima University, Hiroshima, Japan
K Oyama Nagasaki Institute of Applied Science, Nagasaki, Japan
Y Pachmayer Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
S Padhan Indian Institute of Technology Bombay (IIT), Mumbai, India
D Pagano INFN, Sezione di Pavia, Pavia, Italy Università di Brescia, Brescia, Italy
G Paić Instituto de Ciencias Nucleares, Universidad Nacional Autónoma de México, Mexico City, Mexico
A Palasciano INFN, Sezione di Bari, Bari, Italy
S Panebianco Université Paris-Saclay Centre d'Etudes de Saclay (CEA), IRFU, Départment de Physique Nucléaire (DPhN), Saclay, France
H Park University of Tsukuba, Tsukuba, Japan
H Park Sungkyunkwan University, Suwon City, Republic of Korea
J Park Inha University, Incheon, Republic of Korea
J E Parkkila European Organization for Nuclear Research (CERN), Geneva, Switzerland
R N Patra Physics Department, University of Jammu, Jammu, India
B Paul Dipartimento di Fisica dell'Università and Sezione INFN, Cagliari, Italy
H Pei Central China Normal University, Wuhan, China
T Peitzmann Institute for Gravitational and Subatomic Physics (GRASP), Utrecht University/Nikhef, Utrecht, Netherlands
X Peng Central China Normal University, Wuhan, China
M Pennisi Dipartimento di Fisica dell'Università and Sezione INFN, Turin, Italy
L G Pereira Instituto de Física, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil
D Peresunko Affiliated with an institute covered by a cooperation agreement with CERN
G M Perez Centro de Aplicaciones Tecnológicas y Desarrollo Nuclear (CEADEN), Havana, Cuba
S Perrin Université Paris-Saclay Centre d'Etudes de Saclay (CEA), IRFU, Départment de Physique Nucléaire (DPhN), Saclay, France
Y Pestov Affiliated with an institute covered by a cooperation agreement with CERN
V Petráček Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech Republic
V Petrov Affiliated with an institute covered by a cooperation agreement with CERN
M Petrovici Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest, Romania
R P Pezzi Instituto de Física, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil SUBATECH, IMT Atlantique, Nantes Université, CNRS-IN2P3, Nantes, France
S Piano INFN, Sezione di Trieste, Trieste, Italy
M Pikna Comenius University Bratislava, Faculty of Mathematics, Physics and Informatics, Bratislava, Slovak Republic
P Pillot SUBATECH, IMT Atlantique, Nantes Université, CNRS-IN2P3, Nantes, France
O Pinazza European Organization for Nuclear Research (CERN), Geneva, Switzerland INFN, Sezione di Bologna, Bologna, Italy
L Pinsky University of Houston, Houston, Texas, USA
C Pinto Physik Department, Technische Universität München, Munich, Germany
S Pisano INFN, Laboratori Nazionali di Frascati, Frascati, Italy
M Płoskoń Lawrence Berkeley National Laboratory, Berkeley, California, USA
M Planinic Physics department, Faculty of science, University of Zagreb, Zagreb, Croatia
F Pliquett Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
M G Poghosyan Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA
B Polichtchouk Affiliated with an institute covered by a cooperation agreement with CERN
S Politano Dipartimento DISAT del Politecnico and Sezione INFN, Turin, Italy
N Poljak Physics department, Faculty of science, University of Zagreb, Zagreb, Croatia
A Pop Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest, Romania
S Porteboeuf-Houssais Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
V Pozdniakov Affiliated with an international laboratory covered by a cooperation agreement with CERN
K K Pradhan Indian Institute of Technology Indore, Indore, India
S K Prasad Bose Institute, Department of Physics, and Centre for Astroparticle Physics and Space Science (CAPSS), Kolkata, India
S Prasad Indian Institute of Technology Indore, Indore, India
R Preghenella INFN, Sezione di Bologna, Bologna, Italy
F Prino INFN, Sezione di Torino, Turin, Italy
C A Pruneau Wayne State University, Detroit, Michigan, USA
I Pshenichnov Affiliated with an institute covered by a cooperation agreement with CERN
M Puccio European Organization for Nuclear Research (CERN), Geneva, Switzerland
S Pucillo Dipartimento di Fisica dell'Università and Sezione INFN, Turin, Italy
Z Pugelova Technical University of Košice, Košice, Slovak Republic
S Qiu Nikhef, National institute for subatomic physics, Amsterdam, Netherlands
L Quaglia Dipartimento di Fisica dell'Università and Sezione INFN, Turin, Italy
R E Quishpe University of Houston, Houston, Texas, USA
S Ragoni Creighton University, Omaha, Nebraska, USA School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
A Rakotozafindrabe Université Paris-Saclay Centre d'Etudes de Saclay (CEA), IRFU, Départment de Physique Nucléaire (DPhN), Saclay, France
L Ramello INFN, Sezione di Torino, Turin, Italy Università del Piemonte Orientale, Vercelli, Italy
F Rami Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France, Strasbourg, France
S A R Ramirez High Energy Physics Group, Universidad Autónoma de Puebla, Puebla, Mexico
T A Rancien Laboratoire de Physique Subatomique et de Cosmologie, Université Grenoble-Alpes, CNRS-IN2P3, Grenoble, France
M Rasa Dipartimento di Fisica e Astronomia dell'Università and Sezione INFN, Catania, Italy
S S Räsänen Helsinki Institute of Physics (HIP), Helsinki, Finland
R Rath Indian Institute of Technology Indore, Indore, India INFN, Sezione di Bologna, Bologna, Italy
M P Rauch Department of Physics and Technology, University of Bergen, Bergen, Norway
I Ravasenga Nikhef, National institute for subatomic physics, Amsterdam, Netherlands
K F Read Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA University of Tennessee, Knoxville, Tennessee, USA
C Reckziegel Universidade Federal do ABC, Santo Andre, Brazil
A R Redelbach Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
K Redlich National Centre for Nuclear Research, Warsaw, Poland
A Rehman Department of Physics and Technology, University of Bergen, Bergen, Norway
F Reidt European Organization for Nuclear Research (CERN), Geneva, Switzerland
H A Reme-Ness Faculty of Engineering and Science, Western Norway University of Applied Sciences, Bergen, Norway
Z Rescakova Faculty of Science, P.J. Šafárik University, Košice, Slovak Republic
K Reygers Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
A Riabov Affiliated with an institute covered by a cooperation agreement with CERN
V Riabov Affiliated with an institute covered by a cooperation agreement with CERN
R Ricci Dipartimento di Fisica 'E.R. Caianiello' dell' Università and Gruppo Collegato INFN, Salerno, Italy
M Richter Department of Physics, University of Oslo, Oslo, Norway
A A Riedel Physik Department, Technische Universität München, Munich, Germany
W Riegler European Organization for Nuclear Research (CERN), Geneva, Switzerland
C Ristea Institute of Space Science (ISS), Bucharest, Romania
M Rodríguez Cahuantzi High Energy Physics Group, Universidad Autónoma de Puebla, Puebla, Mexico
K Røed Department of Physics, University of Oslo, Oslo, Norway
R Rogalev Affiliated with an institute covered by a cooperation agreement with CERN
E Rogochaya Affiliated with an international laboratory covered by a cooperation agreement with CERN
T S Rogoschinski Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
D Rohr European Organization for Nuclear Research (CERN), Geneva, Switzerland
D Röhrich Department of Physics and Technology, University of Bergen, Bergen, Norway
P F Rojas High Energy Physics Group, Universidad Autónoma de Puebla, Puebla, Mexico
S Rojas Torres Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech Republic
P S Rokita Warsaw University of Technology, Warsaw, Poland
G Romanenko Affiliated with an international laboratory covered by a cooperation agreement with CERN
F Ronchetti INFN, Laboratori Nazionali di Frascati, Frascati, Italy
A Rosano Dipartimento di Scienze MIFT, Università di Messina, Messina, Italy INFN, Sezione di Catania, Catania, Italy
E D Rosas Instituto de Ciencias Nucleares, Universidad Nacional Autónoma de México, Mexico City, Mexico
A Rossi INFN, Sezione di Padova, Padova, Italy
A Roy Indian Institute of Technology Indore, Indore, India
S Roy Indian Institute of Technology Bombay (IIT), Mumbai, India
N Rubini Dipartimento di Fisica e Astronomia dell'Università and Sezione INFN, Bologna, Italy
O V Rueda Lund University Department of Physics, Division of Particle Physics, Lund, Sweden University of Houston, Houston, Texas, USA
D Ruggiano Warsaw University of Technology, Warsaw, Poland
R Rui Dipartimento di Fisica dell'Università and Sezione INFN, Trieste, Italy
B Rumyantsev Affiliated with an international laboratory covered by a cooperation agreement with CERN
P G Russek AGH University of Science and Technology, Cracow, Poland
R Russo Nikhef, National institute for subatomic physics, Amsterdam, Netherlands
A Rustamov National Nuclear Research Center, Baku, Azerbaijan
E Ryabinkin Affiliated with an institute covered by a cooperation agreement with CERN
Y Ryabov Affiliated with an institute covered by a cooperation agreement with CERN
A Rybicki The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
H Rytkonen University of Jyväskylä, Jyväskylä, Finland
W Rzesa Warsaw University of Technology, Warsaw, Poland
O A M Saarimaki Helsinki Institute of Physics (HIP), Helsinki, Finland
R Sadek SUBATECH, IMT Atlantique, Nantes Université, CNRS-IN2P3, Nantes, France
S Sadhu Dipartimento Interateneo di Fisica 'M. Merlin' and Sezione INFN, Bari, Italy
S Sadovsky Affiliated with an institute covered by a cooperation agreement with CERN
J Saetre Department of Physics and Technology, University of Bergen, Bergen, Norway
K Šafařík Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University in Prague, Prague, Czech Republic
S K Saha Bose Institute, Department of Physics, and Centre for Astroparticle Physics and Space Science (CAPSS), Kolkata, India
S Saha National Institute of Science Education and Research, Homi Bhabha National Institute, Jatni, India
B Sahoo Indian Institute of Technology Bombay (IIT), Mumbai, India
R Sahoo Indian Institute of Technology Indore, Indore, India
S Sahoo Institute of Physics, Homi Bhabha National Institute, Bhubaneswar, India
D Sahu Indian Institute of Technology Indore, Indore, India
P K Sahu Institute of Physics, Homi Bhabha National Institute, Bhubaneswar, India
J Saini Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
K Sajdakova Faculty of Science, P.J. Šafárik University, Košice, Slovak Republic
S Sakai University of Tsukuba, Tsukuba, Japan
M P Salvan Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
S Sambyal Physics Department, University of Jammu, Jammu, India
I Sanna European Organization for Nuclear Research (CERN), Geneva, Switzerland Physik Department, Technische Universität München, Munich, Germany
T B Saramela Universidade de São Paulo (USP), São Paulo, Brazil
D Sarkar Wayne State University, Detroit, Michigan, USA
N Sarkar Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
P Sarma Gauhati University, Department of Physics, Guwahati, India
V Sarritzu Dipartimento di Fisica dell'Università and Sezione INFN, Cagliari, Italy
V M Sarti Physik Department, Technische Universität München, Munich, Germany
M H P Sas Yale University, New Haven, Connecticut, USA
J Schambach Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA
H S Scheid Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
C Schiaua Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest, Romania
R Schicker Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
A Schmah Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
C Schmidt Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
H R Schmidt Physikalisches Institut, Eberhard-Karls-Universität Tübingen, Tubingen, Germany
M O Schmidt European Organization for Nuclear Research (CERN), Geneva, Switzerland
M Schmidt Physikalisches Institut, Eberhard-Karls-Universität Tübingen, Tubingen, Germany
N V Schmidt Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA
A R Schmier University of Tennessee, Knoxville, Tennessee, USA
R Schotter Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France, Strasbourg, France
A Schröter Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
J Schukraft European Organization for Nuclear Research (CERN), Geneva, Switzerland
K Schwarz Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
K Schweda Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
G Scioli Dipartimento di Fisica e Astronomia dell'Università and Sezione INFN, Bologna, Italy
E Scomparin INFN, Sezione di Torino, Turin, Italy
J E Seger Creighton University, Omaha, Nebraska, USA
Y Sekiguchi University of Tokyo, Tokyo, Japan
D Sekihata University of Tokyo, Tokyo, Japan
I Selyuzhenkov Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany Affiliated with an institute covered by a cooperation agreement with CERN
S Senyukov Université de Strasbourg, CNRS, IPHC UMR 7178, F-67000 Strasbourg, France, Strasbourg, France
J J Seo Inha University, Incheon, Republic of Korea
D Serebryakov Affiliated with an institute covered by a cooperation agreement with CERN
L Šerkšnytė Physik Department, Technische Universität München, Munich, Germany
A Sevcenco Institute of Space Science (ISS), Bucharest, Romania
T J Shaba iThemba LABS, National Research Foundation, Somerset West, South Africa
A Shabetai SUBATECH, IMT Atlantique, Nantes Université, CNRS-IN2P3, Nantes, France
R Shahoyan European Organization for Nuclear Research (CERN), Geneva, Switzerland
A Shangaraev Affiliated with an institute covered by a cooperation agreement with CERN
A Sharma Physics Department, Panjab University, Chandigarh, India
D Sharma Indian Institute of Technology Bombay (IIT), Mumbai, India
H Sharma The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
M Sharma Physics Department, University of Jammu, Jammu, India
S Sharma Nagasaki Institute of Applied Science, Nagasaki, Japan
S Sharma Physics Department, University of Jammu, Jammu, India
U Sharma Physics Department, University of Jammu, Jammu, India
A Shatat Laboratoire de Physique des 2 Infinis, Irène Joliot-Curie, Orsay, France
O Sheibani University of Houston, Houston, Texas, USA
K Shigaki Physics Program and International Institute for Sustainability with Knotted Chiral Meta Matter (SKCM2), Hiroshima University, Hiroshima, Japan
M Shimomura Nara Women's University (NWU), Nara, Japan
J Shin Chungbuk National University, Cheongju, Republic of Korea
S Shirinkin Affiliated with an institute covered by a cooperation agreement with CERN
Q Shou Fudan University, Shanghai, China
Y Sibiriak Affiliated with an institute covered by a cooperation agreement with CERN
S Siddhanta INFN, Sezione di Cagliari, Cagliari, Italy
T Siemiarczuk National Centre for Nuclear Research, Warsaw, Poland
T F Silva Universidade de São Paulo (USP), São Paulo, Brazil
D Silvermyr Lund University Department of Physics, Division of Particle Physics, Lund, Sweden
T Simantathammakul Suranaree University of Technology, Nakhon Ratchasima, Thailand
R Simeonov Faculty of Physics, Sofia University, Sofia, Bulgaria
B Singh Physics Department, University of Jammu, Jammu, India
B Singh Physik Department, Technische Universität München, Munich, Germany
R Singh National Institute of Science Education and Research, Homi Bhabha National Institute, Jatni, India
R Singh Physics Department, University of Jammu, Jammu, India
R Singh Indian Institute of Technology Indore, Indore, India
S Singh Department of Physics, Aligarh Muslim University, Aligarh, India
V K Singh Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
V Singhal Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
T Sinha Saha Institute of Nuclear Physics, Homi Bhabha National Institute, Kolkata, India
B Sitar Comenius University Bratislava, Faculty of Mathematics, Physics and Informatics, Bratislava, Slovak Republic
M Sitta INFN, Sezione di Torino, Turin, Italy Università del Piemonte Orientale, Vercelli, Italy
T B Skaali Department of Physics, University of Oslo, Oslo, Norway
G Skorodumovs Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
M Slupecki Helsinki Institute of Physics (HIP), Helsinki, Finland
N Smirnov Yale University, New Haven, Connecticut, USA
R J M Snellings Institute for Gravitational and Subatomic Physics (GRASP), Utrecht University/Nikhef, Utrecht, Netherlands
E H Solheim Department of Physics, University of Oslo, Oslo, Norway
J Song University of Houston, Houston, Texas, USA
A Songmoolnak Suranaree University of Technology, Nakhon Ratchasima, Thailand
F Soramel Dipartimento di Fisica e Astronomia dell'Università and Sezione INFN, Padova, Italy
R Spijkers Nikhef, National institute for subatomic physics, Amsterdam, Netherlands
I Sputowska The Henryk Niewodniczanski Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
J Staa Lund University Department of Physics, Division of Particle Physics, Lund, Sweden
J Stachel Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
I Stan Institute of Space Science (ISS), Bucharest, Romania
P J Steffanic University of Tennessee, Knoxville, Tennessee, USA
S F Stiefelmaier Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
D Stocco SUBATECH, IMT Atlantique, Nantes Université, CNRS-IN2P3, Nantes, France
I Storehaug Department of Physics, University of Oslo, Oslo, Norway
P Stratmann Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Munster, Germany
S Strazzi Dipartimento di Fisica e Astronomia dell'Università and Sezione INFN, Bologna, Italy
C P Stylianidis Nikhef, National institute for subatomic physics, Amsterdam, Netherlands
A A P Suaide Universidade de São Paulo (USP), São Paulo, Brazil
C Suire Laboratoire de Physique des 2 Infinis, Irène Joliot-Curie, Orsay, France
M Sukhanov Affiliated with an institute covered by a cooperation agreement with CERN
M Suljic European Organization for Nuclear Research (CERN), Geneva, Switzerland
R Sultanov Affiliated with an institute covered by a cooperation agreement with CERN
V Sumberia Physics Department, University of Jammu, Jammu, India
S Sumowidagdo National Research and Innovation Agency - BRIN, Jakarta, Indonesia
S Swain Institute of Physics, Homi Bhabha National Institute, Bhubaneswar, India
I Szarka Comenius University Bratislava, Faculty of Mathematics, Physics and Informatics, Bratislava, Slovak Republic
S F Taghavi Physik Department, Technische Universität München, Munich, Germany
G Taillepied Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
J Takahashi Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil
G J Tambave Department of Physics and Technology, University of Bergen, Bergen, Norway
S Tang Central China Normal University, Wuhan, China Université Clermont Auvergne, CNRS/IN2P3, LPC, Clermont-Ferrand, France
Z Tang University of Science and Technology of China, Hefei, China
J D Tapia Takaki University of Kansas, Lawrence, Kansas, USA
N Tapus University Politehnica of Bucharest, Bucharest, Romania
L A Tarasovicova Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Munster, Germany
M G Tarzila Horia Hulubei National Institute of Physics and Nuclear Engineering, Bucharest, Romania
G F Tassielli Dipartimento Interateneo di Fisica 'M. Merlin' and Sezione INFN, Bari, Italy
A Tauro European Organization for Nuclear Research (CERN), Geneva, Switzerland
G Tejeda Muñoz High Energy Physics Group, Universidad Autónoma de Puebla, Puebla, Mexico
A Telesca European Organization for Nuclear Research (CERN), Geneva, Switzerland
L Terlizzi Dipartimento di Fisica dell'Università and Sezione INFN, Turin, Italy
C Terrevoli University of Houston, Houston, Texas, USA
G Tersimonov Bogolyubov Institute for Theoretical Physics, National Academy of Sciences of Ukraine, Kiev, Ukraine
S Thakur Bose Institute, Department of Physics, and Centre for Astroparticle Physics and Space Science (CAPSS), Kolkata, India
D Thomas The University of Texas at Austin, Austin, Texas, USA
A Tikhonov Affiliated with an institute covered by a cooperation agreement with CERN
A R Timmins University of Houston, Houston, Texas, USA
M Tkacik Technical University of Košice, Košice, Slovak Republic
T Tkacik Technical University of Košice, Košice, Slovak Republic
A Toia Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
R Tokumoto Physics Program and International Institute for Sustainability with Knotted Chiral Meta Matter (SKCM2), Hiroshima University, Hiroshima, Japan
N Topilskaya Affiliated with an institute covered by a cooperation agreement with CERN
M Toppi INFN, Laboratori Nazionali di Frascati, Frascati, Italy
F Torales-Acosta Department of Physics, University of California, Berkeley, California, USA
T Tork Laboratoire de Physique des 2 Infinis, Irène Joliot-Curie, Orsay, France
A G Torres Ramos Dipartimento Interateneo di Fisica 'M. Merlin' and Sezione INFN, Bari, Italy
A Trifiró Dipartimento di Scienze MIFT, Università di Messina, Messina, Italy INFN, Sezione di Catania, Catania, Italy
A S Triolo Dipartimento di Scienze MIFT, Università di Messina, Messina, Italy INFN, Sezione di Catania, Catania, Italy
S Tripathy INFN, Sezione di Bologna, Bologna, Italy
T Tripathy Indian Institute of Technology Bombay (IIT), Mumbai, India
S Trogolo European Organization for Nuclear Research (CERN), Geneva, Switzerland
V Trubnikov Bogolyubov Institute for Theoretical Physics, National Academy of Sciences of Ukraine, Kiev, Ukraine
W H Trzaska University of Jyväskylä, Jyväskylä, Finland
T P Trzcinski Warsaw University of Technology, Warsaw, Poland
A Tumkin Affiliated with an institute covered by a cooperation agreement with CERN
R Turrisi INFN, Sezione di Padova, Padova, Italy
T S Tveter Department of Physics, University of Oslo, Oslo, Norway
K Ullaland Department of Physics and Technology, University of Bergen, Bergen, Norway
B Ulukutlu Physik Department, Technische Universität München, Munich, Germany
A Uras Université de Lyon, CNRS/IN2P3, Institut de Physique des 2 Infinis de Lyon, Lyon, France
M Urioni INFN, Sezione di Pavia, Pavia, Italy Università di Brescia, Brescia, Italy
G L Usai Dipartimento di Fisica dell'Università and Sezione INFN, Cagliari, Italy
M Vala Faculty of Science, P.J. Šafárik University, Košice, Slovak Republic
N Valle Dipartimento di Fisica, Università di Pavia, Pavia, Italy
L V R van Doremalen Institute for Gravitational and Subatomic Physics (GRASP), Utrecht University/Nikhef, Utrecht, Netherlands
M van Leeuwen Nikhef, National institute for subatomic physics, Amsterdam, Netherlands
C A van Veen Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
R J G van Weelden Nikhef, National institute for subatomic physics, Amsterdam, Netherlands
P Vande Vyvre European Organization for Nuclear Research (CERN), Geneva, Switzerland
D Varga Wigner Research Centre for Physics, Budapest, Hungary
Z Varga Wigner Research Centre for Physics, Budapest, Hungary
M Vasileiou National and Kapodistrian University of Athens, School of Science, Department of Physics, Athens, Greece
A Vasiliev Affiliated with an institute covered by a cooperation agreement with CERN
O Vázquez Doce INFN, Laboratori Nazionali di Frascati, Frascati, Italy
V Vechernin Affiliated with an institute covered by a cooperation agreement with CERN
E Vercellin Dipartimento di Fisica dell'Università and Sezione INFN, Turin, Italy
S Vergara Limón High Energy Physics Group, Universidad Autónoma de Puebla, Puebla, Mexico
L Vermunt Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
R Vértesi Wigner Research Centre for Physics, Budapest, Hungary
M Verweij Institute for Gravitational and Subatomic Physics (GRASP), Utrecht University/Nikhef, Utrecht, Netherlands
L Vickovic Faculty of Electrical Engineering, Mechanical Engineering and Naval Architecture, University of Split, Split, Croatia
Z Vilakazi University of the Witwatersrand, Johannesburg, South Africa
O Villalobos Baillie School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
G Vino INFN, Sezione di Bari, Bari, Italy
A Vinogradov Affiliated with an institute covered by a cooperation agreement with CERN
T Virgili Dipartimento di Fisica 'E.R. Caianiello' dell' Università and Gruppo Collegato INFN, Salerno, Italy
V Vislavicius Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
A Vodopyanov Affiliated with an international laboratory covered by a cooperation agreement with CERN
B Volkel European Organization for Nuclear Research (CERN), Geneva, Switzerland
M A Völkl Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
K Voloshin Affiliated with an institute covered by a cooperation agreement with CERN
S A Voloshin Wayne State University, Detroit, Michigan, USA
G Volpe Dipartimento Interateneo di Fisica 'M. Merlin' and Sezione INFN, Bari, Italy
B von Haller European Organization for Nuclear Research (CERN), Geneva, Switzerland
I Vorobyev Physik Department, Technische Universität München, Munich, Germany
N Vozniuk Affiliated with an institute covered by a cooperation agreement with CERN
J Vrláková Faculty of Science, P.J. Šafárik University, Košice, Slovak Republic
C Wang Fudan University, Shanghai, China
D Wang Fudan University, Shanghai, China
Y Wang Fudan University, Shanghai, China
A Wegrzynek European Organization for Nuclear Research (CERN), Geneva, Switzerland
F T Weiglhofer Frankfurt Institute for Advanced Studies, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
S C Wenzel European Organization for Nuclear Research (CERN), Geneva, Switzerland
J P Wessels Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Munster, Germany
S L Weyhmiller Yale University, New Haven, Connecticut, USA
J Wiechula Institut für Kernphysik, Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany
J Wikne Department of Physics, University of Oslo, Oslo, Norway
G Wilk National Centre for Nuclear Research, Warsaw, Poland
J Wilkinson Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
G A Willems Westfälische Wilhelms-Universität Münster, Institut für Kernphysik, Munster, Germany
B Windelband Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
M Winn Université Paris-Saclay Centre d'Etudes de Saclay (CEA), IRFU, Départment de Physique Nucléaire (DPhN), Saclay, France
J R Wright The University of Texas at Austin, Austin, Texas, USA
W Wu Fudan University, Shanghai, China
Y Wu University of Science and Technology of China, Hefei, China
R Xu Central China Normal University, Wuhan, China
A Yadav Helmholtz-Institut für Strahlen- und Kernphysik, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany
A K Yadav Variable Energy Cyclotron Centre, Homi Bhabha National Institute, Kolkata, India
S Yalcin KTO Karatay University, Konya, Turkey
Y Yamaguchi Physics Program and International Institute for Sustainability with Knotted Chiral Meta Matter (SKCM2), Hiroshima University, Hiroshima, Japan
K Yamakawa Physics Program and International Institute for Sustainability with Knotted Chiral Meta Matter (SKCM2), Hiroshima University, Hiroshima, Japan
S Yang Department of Physics and Technology, University of Bergen, Bergen, Norway
S Yano Physics Program and International Institute for Sustainability with Knotted Chiral Meta Matter (SKCM2), Hiroshima University, Hiroshima, Japan
Z Yin Central China Normal University, Wuhan, China
I-K Yoo Department of Physics, Pusan National University, Pusan, Republic of Korea
J H Yoon Inha University, Incheon, Republic of Korea
S Yuan Department of Physics and Technology, University of Bergen, Bergen, Norway
A Yuncu Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
V Zaccolo Dipartimento di Fisica dell'Università and Sezione INFN, Trieste, Italy
C Zampolli European Organization for Nuclear Research (CERN), Geneva, Switzerland
F Zanone Physikalisches Institut, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
N Zardoshti European Organization for Nuclear Research (CERN), Geneva, Switzerland School of Physics and Astronomy, University of Birmingham, Birmingham, United Kingdom
A Zarochentsev Affiliated with an institute covered by a cooperation agreement with CERN
P Závada Institute of Physics of the Czech Academy of Sciences, Prague, Czech Republic
N Zaviyalov Affiliated with an institute covered by a cooperation agreement with CERN
M Zhalov Affiliated with an institute covered by a cooperation agreement with CERN
B Zhang Central China Normal University, Wuhan, China
L Zhang Fudan University, Shanghai, China
S Zhang Fudan University, Shanghai, China
X Zhang Central China Normal University, Wuhan, China
Y Zhang University of Science and Technology of China, Hefei, China
Z Zhang Central China Normal University, Wuhan, China
M Zhao China Institute of Atomic Energy, Beijing, China
V Zherebchevskii Affiliated with an institute covered by a cooperation agreement with CERN
Y Zhi China Institute of Atomic Energy, Beijing, China
D Zhou Central China Normal University, Wuhan, China
Y Zhou Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
J Zhu Central China Normal University, Wuhan, China Research Division and ExtreMe Matter Institute EMMI, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
Y Zhu Central China Normal University, Wuhan, China
S C Zugravel INFN, Sezione di Torino, Turin, Italy
N Zurlo INFN, Sezione di Pavia, Pavia, Italy Università di Brescia, Brescia, Italy

Collapse

Whole-genome shotgun sequencing unravels the influence of environmental microbial co-infections on the treatment efficacy for severe pediatric infectious diseases

Background

The microbiome plays a pivotal role in mediating immune deviation during the development of early-life viral infections. Recurrent infections in children are considered a risk factor for disease development. This study delves into the metagenomics of the microbiome in children suffering from severe infections, seeking to identify potential sources of these infections.

Aims

The aim of this study was to identify the specific microorganisms and factors that significantly influence the treatment duration in patients suffering from severe infections. We sought to understand how these microbial communities and other variables may affect the treatment duration and the use of antibiotics of these patients with severe infections.

Method

Whole-genome shotgun sequencing was conducted on samples collected from children aged 0-14 years with severe infections, admitted to the Pediatrics Department of Xiamen First Hospital. The Kraken2 algorithm was used for taxonomic identification from sequence reads, and linear mixed models were employed to identify significant microorganisms influencing treatment duration. Colwellia, Cryptococcus, and Citrobacter were found to significantly correlate with the duration of clinical treatment. Further analysis using propensity score matching (PSM) and rank-sum test identified clinical indicators significantly associated with the presence of these microorganisms.

Results

Using a linear mixed model after removed the outliers, we identified that the abundance of Colwellia, Cryptococcus, and Citrobacter significantly influences the treatment duration. The presence of these microorganisms is associated with a longer treatment duration for patients. Furthermore, these microorganisms were found to impact various clinical measures. Notably, an increase in hospitalization durations and medication costs was observed in patients with these microorganisms. In patients with Colwellia, Cryptococcus, and Citrobacter, we discover significant differences in platelets levels. We also find that in patients with Cryptococcus, white blood cells, hemoglobin, and neutrophils levels are lower.

Conclusion

These findings suggest that Colwellia, Cryptococcus, and Citrobacter, particularly Cryptococcus, could potentially contribute to the severity of infections observed in this cohort, possibly as co-infections. These microorganisms warrant further investigation into their pathogenic roles and mechanisms of action, as their presence in combination with disease-causing organisms may have a synergistic effect on disease severity. Understanding the interplay between these microorganisms and pathogenic agents could provide valuable insights into the complex nature of severe pediatric infections and guide the development of targeted therapeutic strategies.

Transcriptome Analysis of Brain and Skin Reveals Immune Responses to Acute Hypoxia and Reoxygenation in Pseudobagrus ussuriensis

Pseudobagrus ussuriensis is an unscaled fish that is more susceptible to skin damage than scaled fish. To investigate the impacts of hypoxia and reoxygenation on skin and brain immunity, juvenile P. ussuriensis were subjected to hypoxia conditions (DO: 0.8 ± 0.05 mg/L) for durations of 0, 3, 6, and 12 h, followed by 12 h of reoxygenation (DO > 6 mg/L). Histological analysis showed a significant increase in the number of skin mucosal cells after 12 h of hypoxia and a significant decrease after 12 h of reoxygenation when compared to the control group. As the duration of hypoxia increased, an increase in antioxidant (SOD, CAT, GSH, MDA) and immune (cortisol, LZM) physiological parameters of the skin and brain appeared. The results of transcriptomic studies showed that the number of differential genes was greater in skin than in brain. Most of the immune pathways in both tissues under hypoxia conditions were all nonspecific immunity (TNF, IL-17, chemokines), while both tissues maintained their homeostasis through active energy supply and cell cycle regulation. Meanwhile, both physiological parameters and RNA transcriptome results showed that 12 h of reoxygenation could not completely eliminate the negative effects of 12 h of hypoxia. This study offers new insights into the immune responses of P. ussuriensis skin and brain during acute hypoxia and reoxygenation.

Tamoxifen Alleviates Endometrial Fibrosis Induced by Anhydrous Ethanol in Rats

BACKGROUND

As an estrogen receptor modulator, tamoxifen has been utilized in the treatment of fibrotic diseases. However, there is a limited body of research focusing on its potential application in addressing endometrial fibrosis conditions. Our research aims to investigate the effects of tamoxifen at different dosage levels in alleviating endometrial fibrosis and to elucidate its mechanisms of action during the initial stages of endometrial damage.

METHODS

A total of thirty sexually mature, unmated female Sprague-Dawley (SD) rats were divided into six distinct groups. To establish the rat uterine adhesion model, the uterine cavity was subjected to perfusion with anhydrous ethanol. The control group received a saline solution, while the treatment group was administered oral estrogen in combination with tamoxifen at doses of 4 mg/kg/d, 20 mg/kg/d, and 40 mg/kg/d. Various techniques, including Hematoxylin and Eosin (HE) staining, Masson's Trichrome staining, Western Blotting analysis, and immunohistochemistry, were employed to assess changes in endometrial thickness, fibrosis, as well as alterations in indicators related to epithelial-mesenchymal transition (EMT), fibrosis, estrogen receptors within the endometrium, and vascular endothelial growth factor (VEGF).

RESULTS

In the model group, the levels of endometrial thickness, E-cadherin, Vimentin, estrogen receptor α (ERα), G protein-coupled receptor 30 (GPR30), and VEGF proteins were significantly lower compared to the control group. Conversely, the levels of collagen accumulation, Smooth Muscle Actin (SMA), Transforming Growth Factor β1 (TGFβ1), Drosophila mothers against decapentaplegic protein 2 (Smad2) , and Smad3 were markedly higher than those observed in the control group (p < 0.05, p < 0.01, p < 0.001, p < 0.0001). In contrast, the low-dose tamoxifen group demonstrated significant increases in endometrial thickness, E-cadherin, Vimentin, ERα, GPR30, and VEGF when compared to the model group (p < 0.05, p < 0.01, p < 0.001, p < 0.0001). Moreover, the levels of collagen accumulation, TGFβ1, SMA, Smad2, and Smad3, which are indicative of fibrosis and the TGFβ1/Drosophila mothers against decapentaplegic (smad) pathway, were notably reduced compared to the model group (p < 0.05, p < 0.0001).

CONCLUSIONS

The results of this study suggest that the administration of a low dose (4 mg/kg/d) of tamoxifen in the early stages of endometrial injury may mitigate epithelial-mesenchymal transition (EMT) indicators and reduce fibrosis within the endometrium induced by anhydrous ethanol.

In-situ biophysical characterization of high-concentration protein formulations using wNMR

High-concentration protein formulation is of paramount importance in patient-centric drug product development, but it also presents challenges due to the potential for enhanced aggregation and increased viscosity. The analysis of critical quality attributes often necessitates the transfer of samples from their primary containers together with sample dilution. Therefore, there is a demand for noninvasive, in situ biophysical methods to assess protein drug products directly in primary sterile containers, such as prefilled syringes, without dilution. In this study, we introduce a novel application of water proton nuclear magnetic resonance (wNMR) to evaluate the aggregation propensity of a high-concentration drug product, Dupixent® (dupilumab), under stress conditions. wNMR results demonstrate a concentration-dependent, reversible association of dupilumab in the commercial formulation, as well as irreversible aggregation when exposed to accelerated thermal stress, but gradually reversible aggregation when exposed to freeze and thaw cycles. Importantly, these results show a strong correlation with data obtained from established biophysical analytical tools widely used in the pharmaceutical industry. The application of wNMR represents a promising approach for in situ noninvasive analysis of high-concentration protein formulations directly in their primary containers, providing valuable insights for drug development and quality assessment.

[Effect of adenovirus-mediated shRNA down-regulates SHP2 expression on the apoptosis of human hepatic stellate cells LX-2]

Objective: To investigate the effect of adenovirus-mediated short hairpin RNA (shRNA) downregulating SH2 domain-containing protein tyrosine phosphatase 2 (SHP2) on the apoptosis of human hepatic stellate cells LX-2 cultured in vitro. Methods: The recombinant adenovirus Ad-shRNA/SHP2 carrying shRNA targeted SHP2 and expressing green fluorescent protein (GFP), and the empty control virus Ad-GFP expressing GFP were transfected into LX-2 cells cultured in vitro. Real-time fluorescence quantitative PCR was used to detect SHP2 mRNA expression in LX-2 cells. Western blot was used to detect the protein expressions of SHP2, Bax, and Bcl-2 in LX-2 cells. TUNEL and annexin-V/propidium iodide dual-labeled flow cytometry were used to detect apoptosis in LX-2 cells. Experimental group: (1) Control group: LX-2 cells were transfected with DMEM instead of adenovirus; (2) Ad-GFP group: transfected with empty virus Ad-GFP; (3) Ad-shRNA/SHP2 group: transfected with recombinant adenovirus Ad-shRNA/SHP2. The means between multiple groups were compared using a one-way ANOVA and the LSD test was used for inter group comparisons. Results: shRNA-targeted SHP2 significantly down-regulated the expression of SHP2 protein and mRNA in LX-2 cells (P < 0.05). The TUNEL and annexin-V/propidium iodide dual-labeled flow cytometry results showed that the apoptosis rate of LX-2 cells in the Ad-shRNA/SHP2 group (12.755%±1.606%, 19.340%±2.505%) (P < 0.05) was significantly higher compared to the control group (3.077%±0.731%, 9.438%±0.804%) and the Ad-GFP group (3.250%±0.851%, 8.893%±1.982%), with no statistically significant difference between the control group and the Ad-GFP group (P > 0.05). Western blot analysis of Bax and Bcl-2 protein expression in LX-2 cells of each group revealed that the Bax protein expression was significantly higher in the Ad shRNA/SHP2 group (2.493 ± 0.203) (P < 0.05) compared to the control group and Ad-GFP group (1.989 ± 0.147, 1.999 ± 0.162), with no statistically significant difference between the control group and the Ad-GFP group (P > 0.05), while the Bcl-2 protein was significantly decreased in the Ad-shRNA/SHP2 group (1.042±0.148) compared with the control group and the Ad-GFP group (1.707±0.146, 1.521±0.142), with no statistically significant difference between the control group and the Ad-GFP group (P > 0.05). Conclusions: SHP2 expression down-regulation induces apoptosis of human hepatic stellate cells LX-2 in vitro by reducing Bcl-2/Bax.

Evaluation of the Needs and Experiences of Patients with Hypertriglyceridemia: Social Media Listening Infosurveillance Study

BACKGROUND

Hypertriglyceridemia is a risk factor for cardiovascular diseases. Internet usage in China is increasing, giving rise to large-scale data sources, especially to access, disseminate, and discuss medical information. Social media listening (SML) is a new approach to analyze and monitor online discussions related to various health-related topics in diverse diseases, which can generate insights into users' experiences and expectations. However, to date, no studies have evaluated the utility of SML to understand patients' cognizance and expectations pertaining to the management of hypertriglyceridemia.

OBJECTIVE

The aim of this study was to utilize SML to explore the disease cognition level of patients with hypertriglyceridemia, choice of intervention measures, and the status quo of online consultations and question-and-answer (Q&A) search platforms.

METHODS

An infosurveillance study was conducted wherein a disease-specific comprehensive search was performed between 2004 and 2020 in Q&A search and online consultation platforms. Predefined single and combined keywords related to hypertriglyceridemia were used in the search, including disease, symptoms, diagnosis, and treatment indicators; lifestyle interventions; and therapeutic agents. The search output was aggregated using an aggregator tool and evaluated.

RESULTS

Disease-specific consultation data (n=69,845) and corresponding response data (n=111,763) were analyzed from 20 data sources (6 Q&A search platforms and 14 online consultation platforms). Doctors from inland areas had relatively high voice volumes and appear to exert a substantial influence on these platforms. Patients with hypertriglyceridemia engaging on the internet have an average level of cognition about the disease and its intervention measures. However, a strong demand for the concept of the disease and "how to treat it" was observed. More emphasis on the persistence of the disease and the safety of medications was observed. Young patients have a lower willingness for drug interventions, whereas patients with severe hypertriglyceridemia have a clearer intention to use drug intervention and few patients have a strong willingness for the use of traditional Chinese medicine.

CONCLUSIONS

Findings from this disease-specific SML study revealed that patients with hypertriglyceridemia in China actively seek information from both online Q&A search and consultation platforms. However, the integrity of internet doctors' suggestions on lifestyle interventions and the accuracy of drug intervention recommendations still need to be improved. Further, a combined prospective qualitative study with SML is required for added rigor and confirmation of the relevance of the findings.

ATXN3 promotes proliferation, stemness and motility of clear cell renal cell carcinoma cells by regulating S100A8 ubiquitination

Background

Clear cell renal cell carcinoma (ccRCC) is a dominant subtype of kidney cancer with a dismal outcome at advanced stages. Ataxin 3 (ATXN3) has been proven to play a cancer-promoting role in several tumors and is upregulated in the patients with renal cell carcinoma. Thus, the objective of this research is to examine the biological roles and underlying mechanisms of ATXN3 in ccRCC.

Methods

Bioinformatics analysis was carried out to analyze ATXN3 expression in ccRCC tissues and patient survival. Gain- and loss-of-function assays were applied to explore the effect of ATXN3 on ccRCC cell malignant behavior in vitro. The effect of ATXN3 on the NF-κB pathway was assessed by Western blot and immunofluorescence staining. The binding between ATXN3 and S100A8 and the effect of ATXN3 on S100A8 ubiquitination were verified using coimmunoprecipitation.

Results

ATXN3 was upregulated in ccRCC tissues and correlated with adverse patient outcome. ATXN3 overexpression facilitated the proliferation, stemness, invasion and migratory capacity of ccRCC cells, whereas silencing had the opposite effect. ATXN3 enhanced the activity of the NF-κB pathway. Silencing ATXN3 facilitated S100A8 ubiquitination. Rescue experiments demonstrated that S100A8 downregulation reversed the promoting effect of ATXN3 on malignant behavior and NF-κB pathway activation in ccRCC cells.

Conclusion

ATXN3 exerts a cancer-promoting effect in ccRCC by regulating S100A8 ubiquitination. Therefore, targeting the ATXN3/S100A8/NF-κB axis may provide a novel underlying therapeutic strategy for ccRCC.

Depletion of gut microbiota facilitates fibroblast growth factor 21-mediated protection against acute pancreatitis in diabetic mice

BACKGROUND

Fibroblast growth factor 21 (FGF21), primarily secreted by the pancreas, liver, and adipose tissues, plays a pivotal role in regulating glucose and lipid metabolism. Acute pancreatitis (AP) is a common inflammatory disease with specific clinical manifestations. Many patients with diabetes present with concurrent inflammatory symptoms. Diabetes exacerbates intestinal permeability and intestinal inflammation, thus leading to the progression to AP. Our previous study indicated that FGF21 significantly attenuated susceptibility to AP in mice.

AIM

To investigate the potential protective role of FGF21 against AP in diabetic mice.

METHODS

In the present study, a mouse model of AP was established in diabetic (db)/db diabetic mice through ceruletide injections. Thereafter, the protective effects of recombinant FGF21 protein against AP were evaluated, with an emphasis on examining serum amylase (AMS) levels and pancreatic and intestinal inflammatory cytokines [interleukin (IL)-6, tumor necrosis factor-alpha (TNF-), and intestinal IL-1β]. Additionally, the impact of this treatment on the histopathologic changes of the pancreas and small intestinal was examined to elucidate the role of FGF21 in diabetic mice with AP. An antibiotic (Abx) cocktail was administered in combination with FGF21 therapy to investigate whether the effect of FGF21 on AP in diabetic mice with AP was mediated through the modulation of the gut microbiota. Subsequently, the Phylogenetic Investigation of Communities by Reconstruction of Unobserved States (PICRUSt), a bioinformatics software package, was used to predict different pathways between the groups and to explore the potential mechanisms by which the gut microbiota influenced the protective effect of FGF21.

RESULTS

The results indicated that FGF21 notably diminished the levels of serum AMS (944.5 ± 15.9 vs 1732 ± 83.9, P < 0.01) and inflammatory factors including IL-6 (0.2400 ± 0.55 vs 1.233 ± 0.053, P < 0.01), TNF- (0.7067 ± 0.22 vs 1.433 ± 0.051, P < 0.01), and IL-1β (1.377 ± 0.069 vs 0.3328 ± 0.02542, P < 0.01) in diabetic mice with AP. Moreover, notable signs of recovery were observed in the pancreatic structure of the mice. The histologic evidence of inflammation in the small intestine, including edema and villous damage, was significantly alleviated. FGF21 also significantly altered the composition of the gut microbiota, reestablishing the Bacteroidetes/Firmicutes ratio. Upon treatment with an Abx cocktail to deplete the gut microbiota, the FGF21 + Abx group showed lower levels of serum AMS (0.9328 ± 0.075 vs 0.2249 ± 0.023, P < 0.01) and inflammatory factors (1.083 ± 0.12 vs 0.2799 ± 0.032, p < 0.01) than the FGF21 group. Furthermore, the FGF21 + Abx group exhibited diminished injury to the pancreatic and small intestinal tissues, accompanied by a significant decrease in blood glucose levels (17.50 ± 1.1 vs 9.817 ± 0.69 mmol/L, P < 0.001). These findings underscored the superior protective effects of the combination therapy involving an Abx cocktail with FGF21 over the FGF21 treatment alone in diabetic mice with AP. The gut microbiota composition across different groups was further characterized, and a differential expression analysis of gene functions was undertaken using the PICRUSt2 prediction method. These findings suggested that FGF21 could potentially confer therapeutic effects on diabetic mice with AP by modulating the sulfate reduction I pathway and the superpathway of n-acetylceramide degradation in the gut microbiota.

CONCLUSION

This study reveals the potential of FGF21 in improving pancreatic and intestinal damage recovery, reducing blood glucose levels, and reshaping gut microbiota composition in diabetic mice with AP. Notably, the protective effects of FGF21 are augmented when combined with the Abx cocktail.

Nuclear factor kappa B (NF-κB) participates in the aluminum-induced down-regulation of miR29a/b1

BACKGROUND

Studies have shown that aluminum (Al) is one of the environmental risk factors leading to Alzheimer's disease (AD), and Al exposure can cause elevated levels of BACE1mRNA, β-secretase (BACE1), and amyloid beta (Aβ) in vivo and in vitro. Previous studies by our research group have shown that this is partly caused by the negative regulation of BACE1 by miRNA29a/b1 (miR29a/b1). Despite the observed the role of nuclear factor kappa B (NF-κB) on many miRNAs, the upstream regulation of NF-κB protein on miR29 remains poorly understood. The purpose of this study was to better define the relationship between NF-κB and miR29a/b1 and the potentially relevant signaling pathways.

METHODS

On the one hand, we constructed the animal model of Al exposure by the intraperitoneal injection of aluminum-maltolate (Al(mal)3) in rats. Conversely, NF- κB inhibitors were added to adrenal phaeochromocytoma (PC12) cells exposed to Al(mal)3.

RESULTS

We verified that NF-κB shows an increasing trend with Al accumulation in the brain of rats, which is accompanied by a downward trend of miR29a/b1. Notably, the suppression of NF-κB significantly increased miR29a/b1 and affected the expression of BACE1mRNA and downstream proteins.

CONCLUSION

Al-induced NF-κB can negatively regulate the expression of miR29a/b1, which then significantly enhances the expression of BACE1 and Aβ plaques.

Circ-ILF2 in oral squamous cell carcinoma promotes cisplatin resistance and induces M2 polarization of macrophages

Cisplatin (CDDP) chemoresistance is one of the predominant factors in oral squamous cell carcinoma (OSCC) treatment failure. Uncovering the mechanisms underlying CDDP resistance is of great importance in OSCC therapy. Circular RNAs (circRNAs) are a newly discovered class of noncoding RNAs, which are reported to participate in the progression of various diseases, including cancer. However, the function of circRNAs in CDDP resistance in OSCC remains unclear. Quantitative reverse transcription PCR was used to search for different circRNAs between OSCC cell lines and CDDP-resistant cell lines. The results showed that circ-ILF2 expression was higher in CDDP-resistant OSCC cell lines. The stability of circ-ILF2 was also confirmed using RNase R and actinomycin D assays. Functional experiments, including cytotoxicity, apoptosis and growth rate assays, showed that upregulation of circ-ILF2 contributes to CDDP resistance. Luciferase reporter-gene, RNA pull-down and quantitative real-time PCR (RT-qPCR) assays showed that circ-ILF2 functions as a microRNA sponge for miR-1252. Luciferase reporter assays, RNA pull-down, RT-qPCR and Western blotting showed that miR-1252 directly targeted and regulated the expression of KLF8. Circ-ILF2 plays an important role in CDDP resistance in OSCC. Circ-ILF2 exerts its function through the miR-1252/KLF8 pathway. In addition, tumour-associated macrophages (TAM) play important roles in cancer progressions, our results showed that circ-ILF2 in OSCC cells induced the M2 polarization of macrophages which provided new thoughts on immunotherapy. Our results suggest that circ-ILF2 may represent a potential therapeutic target in CDDP-resistant OSCC.

Feasibility of transanal minimally invasive surgery for total pelvic exenteration for advanced primary and recurrent pelvic malignancies

BACKGROUND

The purpose of this study was to clarify the efficacy and safety of transanal minimally invasive surgery (TAMIS) for total pelvic exenteration (TPE) in advanced primary and recurrent pelvic malignancies.

METHODS

Using a prospectively collected database, we retrospectively analyzed the clinical, surgical, and pathological outcomes of TAMIS for TPE. Surgery was performed between September 2019 and April 2023. The median follow-up period was 22 months (2-45 months).

RESULTS

Fifteen consecutive patients were included in this analysis M:F = 14:1 and median (range) age was 63 (36-74). Their diagnoses were as follows: primary rectal cancer (n = 5; 33%), recurrent rectal cancer (n = 4; 27%), primary anorectal cancer (n = 5; 33%), and gastrointestinal stromal tumor (n = 1; 7%). Bladder-sparing TPE was selected for two patients (13%). In nine of 15 patients (60%) the anal sphincter could be successfully preserved, five patients (33%) required combined resection of the internal iliac vessels, and two (13%) required rectus muscle flap reconstruction. The median operative time was 723 min (561-1082), and the median intraoperative blood loss was 195 ml (30-1520). The Clavien-Dindo classifications of the postoperative complications were as follows: grade 0-2 (n = 11; 73%); 3a (n = 3; 20%); 3b (n = 1; 7%); and ≥ 4 (n = 0; 0%). No cases of conversion to laparotomy or mortality were observed. The pathological results demonstrated that R0 was achieved in 14 patients (93%).

CONCLUSIONS

The short-term outcomes of this initial experience proved that this novel approach is feasible for TPE, with low blood loss, acceptable postoperative complications, and a satisfactory R0 resection rate.

Modifiable physical and behavioural factors associated with widespread pain in older adults with radiographic evidence of knee osteoarthritis

OBJECTIVE

To identify modifiable physical and behavioural factors associated with widespread pain (WSP) in older adults with radiographic evidence of knee osteoarthritis (OA).

METHODS

Cross-sectional initial visit data of participants with radiographic knee OA (Kellgren-Lawrence grade of ≥2) from the Osteoarthritis Initiative Study were analysed. WSP was defined as pain on both sides of the body, above and below the waist, and in the axial skeleton. Time (hrs/d) spent participating in sitting and moderate-strenuous physical activities were calculated from the Physical Activity Scale for the Elderly questionnaire. Physical function was quantified using gait speed and the chair stand test. Restless sleep was assessed using an item on the CES-D Scale. Logistic regression models were constructed to examine the strength of the associations between primary exposures and WSP in unadjusted and adjusted analyses.

RESULTS

Among the 2637 participants (mean age 62.6 years, 58.6% female), 16.8% met the criteria for WSP. All primary measures of interest were related to WSP in unadjusted analyses. In adjusted multivariable analysis, slow gait speed (adjusted odds ratio [aOR] 1.43; 95% CI 1.01, 2.02), lower chair stand rate (aOR 0.98; 95% CI 0.97-0.99), and restless sleep (aOR 1.61; 95% CI 1.25-2.08) maintained significant associations with WSP.

CONCLUSION

Poor sleep behaviours and low physical function capacity are associated with WSP in adults with radiographic knee OA. These findings highlight the importance of assessing sleep, physical function, and pain distribution in this population. Interventions to improve physical function and sleep behaviours should be investigated as potential strategies to mitigate WSP.

The Natural History of Knee Osteoarthritis Pain Experience and Risk Profiles

The study aimed to characterize the natural history of the pain experience, concurrently considering intermittent and constant pain over 4 years, and determine baseline factors associated with unfavorable trajectories in individuals with chronic knee pain. The Osteoarthritis Initiative (OAI) is a prospective, observational study of people with or at higher risk for knee osteoarthritis. The Intermittent and Constant Osteoarthritis Pain (ICOAP) was assessed annually at 48-to-96-month OAI visits. Twenty-eight baseline sociodemographic, knee-specific, and health-related characteristics were assessed. Group-based dual-trajectory modeling identified pain experience patterns indicated by ICOAP intermittent and constant pain scores over 4 years. Multivariable multinomial logistic regression models determined baseline factors associated with membership in each dual-trajectory group. Four longitudinal pain experience patterns were identified (n = 3,584, mean age = 64.8 [standard deviation 9.0] years, BMI = 28.6 [5.0] kg/m2; 57.9% women). Group 1 (37.7%) had minimal intermittent and no constant pain; Group 2 (35.1%) had mild intermittent and no constant pain; Group 3 (18.5%) had mild intermittent and low-grade constant pain; and Group 4 (8.7%) had moderate intermittent and constant pain. Baseline widespread pain, knee stiffness, back pain, hip pain, ankle pain, obesity, depressive symptoms, more advanced radiographic disease, and analgesic use were each associated with an increased risk of membership in less favorable Groups 2, 3, and 4. These distinct courses of pain experience may be driven by different underlying pain mechanisms. The benchmarked ICOAP scores could be used to stratify patients and tailor management. Addressing and preventing the development of modifiable risks (eg, widespread pain and knee joint stiffness) may reduce the chance of belonging to unfavorable dual-trajectory groups. PERSPECTIVE: Concurrently tracking intermittent versus constant pain experience, group-based dual-trajectory modeling identified 4 distinct pain experience patterns over 4 years. The benchmarked ICOAP scores in these dual trajectories could aid in stratifying patients for tailored management strategies and intensity of care.

Sex Differences in Pain and Quantitative Sensory Testing in Patients With Rheumatoid Arthritis

OBJECTIVE

Women with rheumatoid arthritis (RA) have higher pain and worse functional outcomes compared to men, even when treated with similar medications. The objective of this study was to identify sex differences in pain intensity, pain interference, and quantitative sensory tests (QST), which are independent of inflammation, in patients with RA.

METHODS

This study is a post hoc analysis of participants in the Central Pain in Rheumatoid Arthritis cohort. Pain intensity was assessed using a 0-10 numeric rating scale. Pain interference was measured using a Patient-Reported Outcomes Measurement Information System computerized adaptive test. QST included pressure pain detection thresholds, temporal summation, and conditioned pain modulation. Women and men were compared using multiple linear regression, adjusted for age, education, race, research site, depression, obesity, RA disease duration, swollen joint count, and C-reactive protein.

RESULTS

Mean ± SD pain intensity was 5.32 ± 2.29 among women with RA, compared to 4.60 ± 2.23 among men with RA (adjusted difference 0.83 [95% confidence interval (95% CI) 0.14, 1.53]). Women with RA had lower pressure pain detection thresholds at the trapezius (adjusted difference -1.22 [95% CI -1.73, -0.72]), wrist (adjusted difference -0.57 [95% CI -1.07, -0.06]), and knee (adjusted difference -1.10 [95% CI -2.00, -0.21]). No statistically significant differences in pain interference, temporal summation, and conditioned pain modulation were observed.

CONCLUSION

Women reported higher pain intensity and lower pressure pain detection thresholds (higher pain sensitivity) than men. However, pain interference, temporal summation, and conditioned pain modulation did not differ between men and women.